Document:

<PAGE>
                                                                     Exhibit 4.1

                              JABIL CIRCUIT, INC.

                            2002 STOCK INCENTIVE PLAN

     1. Purposes of the Plan. The purposes of this Stock Incentive Plan are to
attract and retain the best available personnel for positions of substantial
responsibility, to provide additional incentive to Employees and Consultants,
and to promote the success of the Company's business. Awards granted under the
Plan may be Incentive Stock Options, Nonstatutory Stock Options, Stock Awards,
Performance Units, Performance Shares or Stock Appreciation Rights.

     2. Definitions. As used herein, the following definitions shall apply:

         (a) "Administrator" means the Board or any Committee or person as shall
     be administering the Plan, in accordance with Section 4 of the Plan.

         (b) "Applicable Law" means the legal requirements relating to the
     administration of the Plan under applicable federal, state, local and
     foreign corporate, tax and securities laws, and the rules and requirements
     of any stock exchange or quotation system on which the Common Stock is
     listed or quoted

         (c) "Award" means an Option, Stock Appreciation Right, Stock Award,
     Performance Unit or Performance Share granted under the Plan.

         (d) "Award Agreement" means a written agreement by which an Award is
     evidenced.

         (e) "Board" means the Board of Directors of the Company.

         (f) "Change in Control" means the happening of any of the following:

             (i) When any "person," as such term is used in Sections 13 (d) and
         14 (d) of the Exchange Act (other than the Company, a Subsidiary or a
         Company employee benefit plan, including any trustee of such plan
         acting as trustee) is or becomes the "beneficial owner" (as defined in
         Rule 13d-3 under the Exchange Act), directly or indirectly, of
         securities of the Company representing fifty percent (50%) or more of
         the combined voting power of the Company's then outstanding securities;
         or

             (ii) The occurrence of a transaction requiring stockholder
         approval, and involving the sale of all or substantially all of the
         assets of the Company or the merger of the Company with or into another
         corporation.

         (g) "Change in Control Price" means, as determined by the Board,

             (i) the highest Fair Market Value of a Share within the 60 day
         period immediately preceding the date of determination of the Change in
         Control Price by the Board (the "60-Day Period"), or

             (ii) the highest price paid or offered per Share, as determined by
         the Board, in any bona fide transaction or bona fide offer related to
         the Change in Control of the Company, at any time within the 60-Day
         Period, or

             (iii) some lower price as the Board, in its discretion, determines
         to be a reasonable estimate of the fair market value of a Share.

         (h) "Code" means the Internal Revenue Code of 1986, as amended.

         (i) "Committee" means a Committee appointed by the Board in accordance
     with Section 4 of the Plan.
<PAGE>

         (j) "Common Stock" means the Common Stock, $.001 par value, of the
     Company.

         (k) "Company" means Jabil Circuit, Inc., a Delaware corporation.

     (1) "Consultant" means any person, including an advisor, engaged by the
Company or a Parent or Subsidiary to render services and who is compensated for
such services, including without limitation nonEmployee Directors who are paid
only a director's fee by the Company or who are compensated by the Company for
their services as non-Employee Directors. In addition, as used herein,
"consulting relationship" shall be deemed to include service by a non-Employee
Director as such.

     (m) "Continuous Status as an Employee or Consultant" means that the
employment or consulting relationship is not interrupted or terminated by the
Company, any Parent or Subsidiary. Continuous Status as an Employee or
Consultant shall not be considered interrupted in the case of (i) any leave of
absence approved in writing by the Board, an Officer, or a person designated in
writing by the Board or an Officer as authorized to approve a leave of absence,
including sick leave, military leave, or any other personal leave; provided,
however, that for purposes of Incentive Stock Options, any such leave may not
exceed 90 days, unless reemployment upon the expiration of such leave is
guaranteed by contract (including certain Company policies) or statute, or (ii)
transfers between locations of the Company or between the Company, a Parent, a
Subsidiary or successor of the Company; or (iii) a change in the status of the
Grantee from Employee to Consultant or from Consultant to Employee.

     (n) "Covered Stock" means the Common Stock subject to an Award

     (o) "Date of Grant" means the date on which the Administrator makes the
determination granting the Award, or such other later date as is determined by
the Administrator. Notice of the determination shall be provided to each Grantee
within a reasonable time after the Date of Grant.

     (p) "Date of Termination" means the date on which a Grantee's Continuous
Status as an Employee or Consultant terminates.

     (q) "Director" means a member of the Board.

     (r) "Disability" means total and permanent disability as defined in Section
22 (e) (3) of the Code.

     (s) "Employee" means any person, including Officers and Directors, employed
by the Company or any Parent or Subsidiary of the Company. Neither service as a
Director nor payment of a director's fee by the Company shall be sufficient to
constitute "employment" by the Company.

     (t) "Exchange Act" means the Securities Exchange Act of 1934, as amended.

     (u) "Fair Market Value" means, as of any date, the value of Common Stock
determined as follows:

          (i) If the Common Stock is listed on any established stock exchange or
     a national market system, including without limitation the National Market
     System of the National Association of Securities Dealers, Inc. Automated
     Quotation ("NASDAQ") System, the Fair Market Value of a Share of Common
     Stock shall be the closing sales price for such stock (or the closing bid,
     if no sales were reported) as quoted on such system or exchange (or the
     exchange with the greatest volume of trading in Common Stock) on the last
     market trading day prior to the day of determination, as reported in The
     Wall Street Journal or such other source as the Administrator deems
     reliable;

          (ii) If the Common Stock is quoted on the NASDAQ System (but not on
     the National Market System thereof) or is regularly quoted by a recognized
     securities dealer but selling prices are not reported, the Fair Market
     Value of a Share of Common Stock shall be the mean between the high bid and
     low asked prices for the Common Stock on the last market trading day prior
     to the day of determination, as reported in The Wall Street Journal or such
     other source as the Administrator deems reliable;

          (iii) In the absence of an established market for the Common Stock,
     the Fair Market Value shall be

                                       2
<PAGE>

     determined in good faith by the Administrator.

     (v) "Grantee" means an individual who has been granted an Award.

     (w) "Incentive Stock Option" means an Option intended to qualify as an
incentive stock option within the meaning of Section 422 of the Code and the
regulations promulgated thereunder.

         (x) "Mature Shares" means Shares for which the holder thereof has good
     title, free and clear of all liens and encumbrances, and that such holder
     either (i) has held for at least six months or (ii) has purchased on the
     open market.

         (y) "Nonstatutory Stock Option" means an Option not intended to
qualify as an Incentive Stock Option.

         (z) "Officer" means a person who is an officer of the Company within
     the meaning of Section 16 of the Exchange Act and the rules and regulations
     promulgated thereunder.

         (aa) "Option" means a stock option granted under the Plan.

         (bb) "Parent" means a corporation, whether now or hereafter existing,
     in an unbroken chain of corporations ending with the Company if each of the
     corporations other than the Company holds at least 50 percent of the voting
     shares of one of the other corporations in such chain.

         (cc) "Performance Period" means the time period during which the
     performance goals established by the Administrator with respect to a
     Performance Unit or Performance Share, pursuant to Section 9 of the Plan,
     must be met.

         (dd) "Performance Share" has the meaning set forth in Section 9 of the
     Plan.

         (ee) "Performance Unit" has the meaning set forth in Section 9 of the
     Plan.

         (ff) "Plan" means this 2002 Stock Incentive Plan.

         (gg) "Rule 16b-3" means Rule 16b-3 promulgated under the Exchange Act
     or any successor to Rule 16b-3, as in effect when discretion is being
     exercised with respect to the Plan.

         (hh) "Share" means a share of the Common Stock, as adjusted in
     accordance with Section 11 of the Plan.

         (ii) "Stock Appreciation Right" or "SAR" has the meaning set forth in
     Section 7 of the Plan.

         (jj) "Stock Grant" means Shares that are awarded to a Grantee pursuant
     to Section 8 of the Plan.

         (kk) "Subsidiary" means a corporation, domestic or foreign, of which
     not less than 50 percent of the voting shares are held by the Company or a
     Subsidiary, whether or not such corporation now exists or is hereafter
     organized or acquired by the Company or a Subsidiary.

     3. Stock Subject to the Plan. Subject to the provisions of Section 11 of
the Plan and except as otherwise provided in this Section 3, the maximum
aggregate number of Shares that may be subject to Awards under the Plan is
7,000,000 Shares. The Shares may be authorized, but unissued, or reacquired
Common Stock.

     If an Award expires or becomes unexercisable without having been exercised
in full the remaining Shares that were subject to the Award shall become
available for future Awards under the Plan (unless the Plan has terminated). If
any Shares (whether subject to or received pursuant to an Award granted
hereunder, purchased on the open market, or otherwise obtained, and including
Shares that are deemed (by attestation or otherwise) to have been delivered to
the Company as payment for all or any portion of the exercise price of an Award)
are withheld or applied as payment by the Company in connection with the
exercise of an Award or the withholding of taxes related thereto, such Shares,
to the extent of any such withholding or payment, shall again be available or
shall increase the

                                       3
<PAGE>

number of Shares available, as applicable, for future Awards under the Plan. Any
Shares that are authorized to be optioned and sold under the Jabil Circuit, Inc.
1992 Stock Option Plan (the "1992 Plan") and that are not subject to options
granted under the 1992 Plan and outstanding as of the date of termination of the
1992 Plan shall be available or shall increase the number of Shares available,
as applicable, for Awards under the Plan. The Board may from time to time
determine the appropriate methodology for calculating the number of Shares
issued pursuant to the Plan.

4. Administration of the Plan.

     (a) Procedure.

         (i) Multiple Administrative Bodies. The Plan may be administered by
     different bodies with respect to different groups of Employees and
     Consultants. Except as provided below, the Plan shall be administered by
     (A) the Board or (B) a committee designated by the Board and constituted to
     satisfy Applicable Law.

         (ii) Rule 16b-3. To the extent the Board considers it desirable for
     transactions relating to Awards to be eligible to qualify for an exemption
     under Rule 16b-3, the transactions contemplated under the Plan shall be
     structured to satisfy the requirements for exemption under Rule 16b-3.

         (iii) Section 162(m) of the Code. To the extent the Board considers it
     desirable for compensation delivered pursuant to Awards to be eligible to
     qualify for an exemption from the limit on tax deductibility of
     compensation under Section 162(m) of the Code, the transactions
     contemplated under the Plan shall be structured to satisfy the requirements
     for exemption under Section 162(m) of the Code.

         (iv) Authorization of Officers to Grant Options. In accordance with
     Applicable Law, the Board may, by a resolution adopted by the Board,
     authorize one or more Officers to designate Officers and Employees
     (excluding the Officer so authorized) to be Grantees of Options and
     determine the number of Options to be granted to such Officers and
     Employees; provided, however, that the resolution adopted by the Board so
     authorizing such Officer or Officers shall specify the total number and the
     terms (including the exercise price, which may include a formula by which
     such price may be determined) of Options such Officer or Officers may so
     grant.

     (b) Powers of the Administrator. Subject to the provisions of the Plan, and
in the case of a Committee or an Officer, subject to the specific duties
delegated by the Board to such Committee or Committee, the Administrator shall
have the authority, in its sole and absolute discretion:

         (i) to determine the Fair Market Value of the Common Stock, in
     accordance with Section 2(u) of the Plan;

         (ii) to select the Consultants and Employees to whom Awards will be
     granted under the Plan;

         (iii) to determine whether, when, to what extent and in what types and
     amounts Awards are granted under the Plan;

         (iv) to determine the number of shares of Common Stock to be covered by
     each Award granted under the Plan;

         (v) to determine the forms of Award Agreements, which need not be the
     same for each grant or for each Grantee, for use under the Plan;

         (vi) to determine the terms and conditions, not inconsistent with the
     terms of the Plan, of any Award granted under the Plan. Such terms and
     conditions, which need not be the same for each grant or for each Grantee,
     include, but are not limited to, the exercise price, the time or times when
     Options and SARs may be exercised (which may be based on performance
     criteria), the extent to which vesting is suspended during a leave of
     absence, any vesting acceleration or waiver of forfeiture restrictions, and
     any restriction or limitation regarding any Award or the shares of Common
     Stock relating thereto, based in each case on such factors as the
     Administrator shall determine;

                                       4
<PAGE>

         (vii) to construe and interpret the terms of the Plan and Awards;

         (viii) to prescribe, amend and rescind rules and regulations relating
     to the Plan, including, without limiting the generality of the foregoing,
     rules and regulations relating to the operation and administration of the
     Plan to accommodate the specific requirements of local and foreign laws and
     procedures;

         (ix) to modify or amend each Award (subject to Section 13 of the Plan);

         (x) to authorize any person to execute on behalf of the Company any
     instrument required to effect the grant of an Award previously granted by
     the Administrator;

         (xi) to determine the terms and restrictions applicable to Awards;

         (xii) to make such adjustments or modifications to Awards granted to
     Grantees who are Employees of foreign Subsidiaries as are advisable to
     fulfill the purposes of the Plan or to comply with Applicable Law;

         (xiii) to delegate its duties and responsibilities under the Plan with
     respect to sub-plans applicable to foreign Subsidiaries, except its duties
     and responsibilities with respect to Employees who are also Officers or
     Directors subject to Section 16(b) of the Exchange Act; and

         (xiv) to make all other determinations deemed necessary or advisable
     for administering the Plan.

     (c) Effect of Administrator's Decision. The Administrator's decisions,
determinations and interpretations shall be final and binding on all Grantees
and any other holders of Awards.

5. Eligibility and General Conditions of Awards.

     (a) Eligibility. Awards other than Incentive Stock Options may be granted
to Employees and Consultants. Incentive Stock Options may be granted only to
Employees. If otherwise eligible, an Employee or Consultant who has been granted
an Award may be granted additional Awards.

     (b) Maximum Term. Subject to the following provision, the term during which
an Award may be outstanding shall not extend more than ten years after the Date
of Grant, and shall be subject to earlier termination as specified elsewhere in
the Plan or Award Agreement; provided, however, that any deferral of a cash
payment or of the delivery of Shares that is permitted or required by the
Administrator pursuant to Section 10 of the Plan may, if so permitted or
required by the Administrator, extend more than ten years after the Date of
Grant of the Award to which the deferral relates.

     (c) Award Agreement. To the extend not set forth in the Plan, the terms and
conditions of each Award, which need not be the same for each grant or for each
Grantee, shall be set forth in an Award Agreement.

     (d) Termination of Employment or Consulting Relationship. In the event that
a Grantee's Continuous Status as an Employee or Consultant terminates (other
than upon the Grantee's death or Disability), then, unless otherwise provided by
the Award Agreement, and subject to Section 11 of the Plan:

         (i) the Grantee may exercise his or her unexercised Option or SAR, but
     only within such period of time as is determined by the Administrator, and
     only to the extent that the Grantee was entitled to exercise it at the Date
     of Termination (but in no event later than the expiration of the term of
     such Option or SAR as set forth in the Award Agreement). In the case of an
     Incentive Stock Option, the Administrator shall determine such period of
     time (in no event to exceed three months from the Date of Termination) when
     the Option is granted If, at the Date of Termination, the Grantee is not
     entitled to exercise his or her entire Option or SAR, the Shares covered by
     the unexercisable portion of the Option or SAR shall revert to the Plan.
     If, after the Date of Termination, the Grantee does not exercise his or her
     Option or SAR within the time specified by the Administrator, the Option or
     SAR shall terminate, and the Shares covered by such Option or SAR shall
     revert to the Plan. An Award Agreement may also provide that if the
     exercise of an Option following the Date of Termination would be

                                       5
<PAGE>

     prohibited at any time because the issuance of Shares would violate
     Company policy regarding compliance with Applicable Law, then the exercise
     period shall terminate on the earlier of (A) the expiration of the term of
     the Option set forth in Section 6(b) of the Plan or (B) the expiration of a
     period of 10 days after the Date of Termination during which the exercise
     of the Option would not be in violation of such requirements;

          (ii) the Grantee's Stock Awards, to the extent forfeitable immediately
     before the Date of Termination, shall thereupon automatically be forfeited;

          (iii) the Grantee's Stock Awards that were not forfeitable immediately
     before the Date of Termination shall promptly be settled by delivery to the
     Grantee of a number of unrestricted Shares equal to the aggregate number of
     the Grantee's vested Stock Awards;

          (iv) any Performance Shares or Performance Units with respect to which
     the Performance Period has not ended as of the Date of Termination shall
     terminate immediately upon the Date of Termination.

     (e) Disability of Grantee. In the event that a Grantee's Continuous Status
as an Employee or Consultant terminates as a result of the Grantee's Disability,
then, unless otherwise provided by the Award Agreement:

          (i) the Grantee may exercise his or her unexercised Option or SAR at
     any time within 12 months from the Date of Termination, but only to the
     extent that the Grantee was entitled to exercise the Option or SAR at the
     Date of Termination (but in no event later than the expiration of the term
     of the Option or SAR as set forth in the Award Agreement). If, at the Date
     of Termination, the Grantee is not entitled to exercise his or her entire
     Option or SAR, the Shares covered by the unexercisable portion of the
     Option or SAR shall revert to the Plan. If, after the Date of Termination,
     the Grantee does not exercise his or her Option or SAR within the time
     specified herein, the Option or SAR shall terminate, and the Shares covered
     by such Option or SAR shall revert to the Plan.

         (ii) the Grantee's Stock Awards, to the extent forfeitable immediately
     before the Date of Termination, shall thereupon automatically be forfeited;

         (iii) the Grantee's Stock Awards that were not forfeitable immediately
     before the Date of Termination shall promptly be settled by delivery to the
     Grantee of a number of unrestricted Shares equal to the aggregate number of
     the Grantee's vested Stock Awards;

         (iv) any Performance Shares or Performance Units with respect to which
     the Performance Period has not ended as of the Date of Termination shall
     terminate immediately upon the Date of Termination.

     (f) Death of Grantee. In the event of the death of an Grantee, then, unless
otherwise provided by the Award Agreement,

          (i) the Grantee's unexercised Option or SAR may be exercised at any
     time within 12 months following the date of death (but in no event later
     than the expiration of the term of such Option or SAR as set forth in the
     Award Agreement), by the Grantee's estate or by a person who acquired the
     right to exercise the Option or SAR by bequest or inheritance, but only to
     the extent that the Grantee was entitled to exercise the Option or SAR at
     the date of death. If, at the time of death, the Grantee was not entitled
     to exercise his or her entire Option or SAR, the Shares covered by the
     unexercisable portion of the Option or SAR shall immediately revert to the
     Plan. If, after death, the Grantee's estate or a person who acquired the
     right to exercise the Option or SAR by bequest or inheritance does not
     exercise the Option or SAR within the time specified herein, the Option or
     SAR shall terminate, and the Shares covered by such Option or SAR shall
     revert to the Plan.

          (ii) the Grantee's Stock Awards, to the extent forfeitable immediately
     before the date of death, shall thereupon automatically be forfeited;

          (iii) the Grantee's Stock Awards that were not forfeitable immediately
     before the date of death shall promptly be settled by delivery to the
     Grantee's estate or a person who acquired the right to hold the Stock Grant
     by bequest or inheritance, of a number of unrestricted Shares equal to the
     aggregate number of the Grantee's

                                       6
<PAGE>

     vested Stock Awards;

          (iv) any Performance Shares or Performance Units with respect to which
     the Performance Period has not ended as of the date of death shall
     terminate immediately upon the date of death.

          (g) Buyout Provisions. The Administrator may at any time offer to buy
     out, for a payment in cash or Shares, an Award previously granted, based on
     such terms and conditions as the Administrator shall establish and
     communicate to the Grantee at the time that such offer is made. Any such
     cash offer made to an Officer or Director shall comply with the provisions
     of Rule 16b-3 relating to cash settlement of stock appreciation rights.
     This provision is intended only to clarify the powers of the Administrator
     and shall not in any way be deemed to create any rights on the part of
     Grantees to buyout offers or payments.

         (h) Nontransferability of Awards.

          (i) Except as provided in Section 5(h)(iii) below, each Award, and
     each right under any Award, shall be exercisable only by the Grantee during
     the Grantee's lifetime, or, if permissible under Applicable Law, by the
     Grantee's guardian or legal representative.

          (ii) Except as provided in Section 5(h) (iii) below, no Award (prior
     to the time, if applicable, Shares are issued in respect of such Award),
     and no right under any Award, may be assigned, alienated, pledged,
     attached, sold or otherwise transferred to encumbered by a Grantee
     otherwise than by will or by the laws of descent and distribution (or in
     the case of Stock Awards, to the Company) and any such purported
     assignment, alienation, pledge, attachment, sale, transfer or encumbrance
     shall be void and unenforceable against the Company or any Subsidiary;
     provided, that the designation of a beneficiary shall not constitute an
     assignment, alienation, pledge, attachment, sale, transfer or encumbrance.

          (iii) To the extent and in the manner permitted by Applicable Law, and
     to the extent and in the manner permitted by the Administrator, and subject
     to such terms and conditions as may be prescribed by the Administrator, a
     Grantee may transfer an Award to:

          (A) a child, stepchild, grandchild, parent, stepparent, grandparent,
     spouse, former spouse, sibling, niece, nephew, mother-in-law,
     father-in-law, son-in-law, daughter-in-law, brother-in-law, or
     sister-in-law of the Grantee (including adoptive relationships);

          (B) any person sharing the employee's household (other than a tenant
     or employee);

          (C) a trust in which persons described in (A) and (B) have more than
     50 percent of the beneficial interest;

          (D) a foundation in which persons described in (A) or (B) or the
     Grantee control the management of assets; or

          (E) any other entity in which the persons described in (A) or (B) or
     the Grantee own more than 50 percent of the voting interests;

          provided such transfer is not for value. The following shall not be
     considered transfers for value: a transfer under a domestic relations order
     in settlement of marital property rights, and a transfer to an entity in
     which more than 50 percent of the voting interests are owned by persons
     described in (A) above or the Grantee, in exchange for an interest in such
     entity.

         6. Stock Options.

         (a) Limitations.

         (i) Each Option shall be designated in the Award Agreement as either
     an Incentive Stock Option or a Nonstatutory Stock Option. Any Option
     designated as an Incentive Stock Option:

                                       7
<PAGE>

         (A) shall not have an aggregate Fair Market Value (determined for each
         Incentive Stock Option at the Date of Grant) of Shares with respect to
         which Incentive Stock Options are exercisable for the first time by the
         Grantee during any calendar year (under the Plan and any other employee
         stock option plan of the Company or any Parent or Subsidiary ("Other
         Plans")), determined in accordance with the provisions of Section 422
         of the Code, that exceeds $100,000 (the "$100,000 Limit");

              (B) shall, if the aggregate Fair Market Value of Shares
         (determined on the Date of Grant) with respect to the portion of such
         grant that is exercisable for the first time during any calendar year
         ("Current Grant") and all Incentive Stock Options previously granted
         under the Plan and any Other Plans that are exercisable for the first
         time during a calendar year ("Prior Grants") would exceed the $100,000
         Limit, be exercisable as follows:

                  (1) The portion of the Current Grant that would, when added to
              any Prior Grants, be exercisable with respect to Shares that would
              have an aggregate Fair Market Value (determined as of the
              respective Date of Grant for such Options) in excess of the
              $100,000 Limit shall, notwithstanding the terms of the Current
              Grant, be exercisable for the first time by the Grantee in the
              first subsequent calendar year or years in which it could be
              exercisable for the first time by the Grantee when added to all
              Prior Grants without exceeding the $100,000 Limit; and

                  (2) If, viewed as of the date of the Current Grant, any
              portion of a Current Grant could not be exercised under the
              preceding provisions of this Section 6(a) (i) (B) during any
              calendar year commencing with the calendar year in which it is
              first exercisable through and including the last calendar year in
              which it may by its terms be exercised, such portion of the
              Current Grant shall not be an Incentive Stock Option, but shall be
              exercisable as a separate Option at such date or dates as are
              provided in the Current Grant.

         (ii) No Employee shall be granted, in any fiscal year of the Company,
     Options to purchase more than 3,000,000 Shares. The limitation described in
     this Section 6(a)(ii) shall be adjusted proportionately in connection with
     any change in the Company's capitalization as described in Section 11 of
     the Plan. If an Option is canceled in the same fiscal year of the Company
     in which it was granted (other than in connection with a transaction
     described in Section 11 of the Plan), the canceled Option will be counted
     against the limitation described in this Section 6(a) (ii).

     (b) Term of Option. The term of each Option shall be stated in the Award
Agreement; provided, however, that in the case of an Incentive Stock Option, the
term shall be l0 years from the date of grant or such shorter term as may be
provided in the Award Agreement. Moreover, in the case of an Incentive Stock
Option granted to a Grantee who, at the time the Incentive Stock Option is
granted, owns stock representing more than 10 percent of the voting power of all
classes of stock of the Company or any Parent or Subsidiary, the term of the
Incentive Stock Option shall be five years from the date of grant or such
shorter term as may be provided in the Award Agreement.

     (c) Option Exercise Price and Consideration.

         (i) Exercise Price. The per share exercise price for the Shares to be
     issued pursuant to exercise of an Option shall be determined by the
     Administrator and, except as otherwise provided in this Section 6(c) (i),
     shall be no less than 100 percent of the Fair Market Value per Share on the
     Date of Grant.

              (A) In the case of an Incentive Stock Option granted to an
         Employee who on the Date of Grant owns stock representing more than 10
         percent of the voting power of all classes of stock of the Company or
         any Parent or Subsidiary, the per Share exercise price shall be no less
         than 110 percent of the Fair Market Value per Share on the Date of
         Grant.

              (B) Any Option that is (1) granted to a Grantee in connection with
         the acquisition ("Acquisition"), however effected, by the Company of
         another corporation or entity ("Acquired Entity") or the assets
         thereof, (2) associated with an option to purchase shares of stock or
         other equity interest of the Acquired Entity or an affiliate thereof
         ("Acquired Entity Option") held by such Grantee immediately prior to
         such Acquisition, and (3) intended to preserve for the Grantee the
         economic value of all or a portion of such

                                       8
<PAGE>

     Acquired Entity Option, may be granted with such exercise price as the
     Administrator determines to be necessary to achieve such preservation of
     economic value.

             (C) Any Option that is granted to a Grantee not previously employed
         by the Company, or a Parent or Subsidiary, as a material inducement to
         the Grantee's commencing employment with the Company may be granted
         with such exercise price as the Administrator determines to be
         necessary to provide such material inducement.

     (d) Waiting Period and Exercise Dates. At the time an Option is granted,
the Administrator shall fix the period within which the Option may be exercised
and shall determine any conditions that must be satisfied before the Option may
be exercised. An Option shall be exercisable only to the extent that it is
vested according to the terms of the Award Agreement.

     (e) Form of Consideration. The Administrator shall determine the acceptable
form of consideration for exercising an Option, including the method of payment.
In the case of an Incentive Stock Option, the Administrator shall determine the
acceptable form of consideration at the time of grant. The acceptable form of
consideration may consist of any combination of cash, personal check, wire
transfer or, subject to the approval of the Administrator:

         (i) pursuant to rules and procedures approved by the Administrator,
     promissory note;

         (ii) Mature Shares;

         (iii) pursuant to procedures approved by the Committee, (A) through the
     sale of the Shares acquired on exercise of the Option through a
     broker-dealer to whom the Grantee has submitted an irrevocable notice of
     exercise and irrevocable instructions to deliver promptly to the Company
     the amount of sale or loan proceeds sufficient to pay the exercise price,
     together with, if requested by the Company, the amount of federal, state,
     local or foreign withholding taxes payable by the Grantee by reason of such
     exercise, or (B) through simultaneous sale through a broker of Shares
     acquired upon exercise; or

          (iv) such other consideration and method of payment for the issuance
     of Shares to the extent permitted by Applicable Law.

     (f) Exercise of Option.

         (i) Procedure for Exercise; Rights as a Stockholder.

             (A) Any Option granted hereunder shall be exercisable according to
         the terms of the Plan and at such times and under such conditions as
         determined by the Administrator and set forth in the Award Agreement.

                  (B) An Option may not be exercised for a fraction of a Share.

                  (C) An Option shall be deemed exercised when the Company
         receives:

                       (1) written notice of exercise (in accordance with the
                  Award Agreement) from the person entitled to exercise the
                  Option, and

                       (2) full payment for the Shares with respect to which the
                  Option is exercised. Full payment may consist of any
                  consideration and method of payment authorized by the
                  Administrator and permitted by the Award Agreement and the
                  Plan.

                       (3) Shares issued upon exercise of an Option shall be
                  issued in the name of the Grantee or, if requested by the
                  Grantee, in the name of the Grantee and his or her spouse.
                  Until the stock certificate evidencing such Shares is issued
                  (as evidenced by the appropriate entry on the books of the
                  Company or of a duly authorized transfer agent of the
                  Company), no right to vote or receive dividends or any other
                  rights as a stockholder shall exist with respect to the
                  Optioned Stock, notwithstanding the exercise of the Option.
                  The Company shall issue (or cause to be issued) such

                                       9
<PAGE>
                   stock certificate promptly after the Option is
                   exercised. No adjustment will be made for a dividend or
                   other right for which the record date is prior to the date
                   the stock certificate is issued, except as provided in
                   Section 11 of the Plan.

                       (4) Exercising an Option in any manner shall decrease the
                   number of Shares thereafter available, both for purposes of
                   the Plan and for sale under the Option, by the number of
                   Shares as to which the Option is exercised.

     7. Stock Appreciation Rights.

          (a) Grant of SARs. Subject to the terms and conditions of the Plan,
     the Administrator may grant SARs in tandem with an Option or alone and
     unrelated to an Option. Tandem SARs shall expire no later than the
     expiration of the underlying Option.

          (b) Exercise of SARs. SARs shall be exercised by the delivery of a
     written notice of exercise to the Company, setting forth the number of
     Shares over which the SAR is to be exercised. Tandem SARs may be exercised:

              (i) with respect to all or part of the Shares subject to the
         related Option upon the surrender of the right to exercise the
         equivalent portion of the related Option;

              (ii) only with respect to the Shares for which its related Option
         is then e xercisable; and

              (iii) only when the Fair Market Value of the Shares subject to the
         Option exceeds the exercise price of the Option.

         The value of the payment with respect to the tandem SAR may be no more
         than 100 percent of the difference between the exercise price of the
         underlying Option and the Fair Market Value of the Shares subject to
         the underlying Option at the time the tandem SAR is exercised.

          (c) Payment of SAR Benefit. Upon exercise of an SAR, the Grantee shall
     be entitled to receive payment from the Company in an amount determined by
     multiplying:

              (i) the excess of the Fair Market Value of a Share on the date of
         exercise over the SAR exercise price; by

              (ii) the number of Shares with respect to which the SAR is
         exercised;

         provided, that the Administrator may provide in the Award Agreement
         that the benefit payable on exercise of an SAR shall not exceed such
         percentage of the Fair Market Value of a Share on the Date of Grant as
         the Administrator shall specify. As determined by the Administrator,
         the payment upon exercise of an SAR may be in cash, in Shares that have
         an aggregate Fair Market Value (as of the date of exercise of the SAR)
         equal to the amount of the payment, or in some combination thereof, as
         set forth in the Award Agreement.

     8. Stock Awards. Subject to the terms of the Plan, the Administrator  may
grant Stock Awards to any Employee or Consultant, in such amount and upon such
terms and conditions as shall be determined by the Administrator.

     9. Performance Units and Performance Shares.

         (a) Grant of Performance Units and Performance Shares. Subject to the
     terms of the Plan, the Administrator may grant Performance Units or
     Performance Shares to any Employee or Consultant in such amounts and upon
     such terms as the Administrator shall determine.

         (b) Value/Performance Goals. Each Performance Unit shall have an
     initial value that is established by the Administrator on the Date of
     Grant. Each Performance Share shall have an initial value equal to the Fair
     Market Value of a Share on the Date of Grant. The Administrator shall set
     performance goals that, depending upon the

                                       10
<PAGE>

     extent to which they are met, will determine the number or value of
     Performance Units or Performance Shares that will be paid to the Grantee.

         (c) Payment of Performance Units and Performance Shares.

             (i) Subject to the terms of the Plan, after the applicable
         Performance Period has ended, the holder of Performance Units or
         Performance Shares shall be entitled to receive a payment based on the
         number and value of Performance Units or Performance Shares earned by
         the Grantee over the Performance Period, determined as a function of
         the extent to which the corresponding performance goals have been
         achieved.

              (ii) If a Grantee is promoted, demoted or transferred to a
         different business unit of the Company during a Performance Period,
         then, to the extent the Administrator determines appropriate, the
         Administrator may adjust, change or eliminate the performance goals or
         the applicable Performance Period as it deems appropriate in order to
         make them appropriate and comparable to the initial performance goals
         or Performance Period.

         (d) Form and Timing of Payment of Performance Units and Performance
     Shares. Payment of earned Performance Units or Performance Shares shall be
     made in a lump sum following the close of the applicable Performance
     Period. The Administrator may pay earned Performance Units or Performance
     Shares in cash or in Shares (or in a combination thereof) that have an
     aggregate Fair Market Value equal to the value of the earned Performance
     Units or Performance Shares at the close of the applicable Performance
     Period. Such Shares may be granted subject to any restrictions deemed
     appropriate by the Administrator. The form of payout of such Awards shall
     be set forth in the Award Agreement pertaining to the grant of the Award.

     10. Deferral of Receipt of Payment. The Administrator may permit or require
a Grantee to defer receipt of the payment of cash or the delivery of Shares that
would otherwise be due by virtue of the exercise of an Option or SAR, the grant
of or the lapse or waiver of restrictions with respect to Stock Awards or the
satisfaction of any requirements or goals with respect to Performance Units or
Performance Shares. If any such deferral is required or permitted, the
Administrator shall establish such rules and procedures for such deferral.

     11. Adjustments Upon Changes in Capitalization or Change of Control.

         (a) Changes in Capitalization. Subject to any required action by the
     stockholders of the Company, the number of Covered Shares, and the number
     of shares of Common Stock which have been authorized for issuance under the
     Plan but as to which no Awards have yet been granted or which have been
     returned to the Plan upon cancellation or expiration of an Award, as well
     as the price per share of Covered Stock, shall be proportionately adjusted
     for any increase or decrease in the number of issued shares of Common Stock
     resulting from a stock split, reverse stock split, stock dividend,
     combination or reclassification of the Common Stock, or any other increase
     or decrease in the number of issued shares of Common Stock effected without
     receipt of consideration by the Company; provided, however, that conversion
     of any convertible securities of the Company shall not be deemed to have
     been "effected without receipt of consideration." Such adjustment shall be
     made by the Board, whose determination in that respect shall be final,
     binding and conclusive. Except as expressly provided herein, no issuance by
     the Company of shares of stock of any class, or securities convertible into
     shares of stock of any class, shall affect, and no adjustment by reason
     thereof shall be made with respect to, the number or price of shares of
     Covered Stock.

         (b) Change in Control. In the event of a Change in Control, then the
     following provisions shall apply:

             (i) Vesting. Any Award outstanding on the date such Change in
         Control is determined to have occurred that is not yet exercisable and
         vested on such date:

                  (A) shall become fully exercisable and vested on the first
             anniversary of the date of such Change in Control (the "Change in
             Control Anniversary") if the Grantee's Continuous Status as an
             Employee or Consultant does not terminate prior to the Change in
             Control Anniversary;

                  (B) shall become fully exercisable and vested on the Date of
             Termination if the Grantee's

                                       11
<PAGE>

             Continuous Status as an Employee or Consultant terminates prior to
             the Chang e in Control Anniversary as a result of termination by
             the Company without Cause or resignation by the Grantee for Good
             Reason; or

          (C) shall not become full exercisable and vested if the Grantee's
     Continuous Status as an Employee or Consultant terminates prior to the
     Change in Control Anniversary as a result of termination by the Company for
     Cause or resignation by the Grantee without Good Reason.

     For purposes of this Section 11(b)(i), the following definitions shall
     apply:

          (D) "Cause" means:

              (1) A Grantee's conviction of a crime involving fraud or
         dishonesty; or

              (2) A Grantee's continued willful or reckless material misconduct
         in the performance of the Grantee's duties after receipt of written
         notice from the Company concerning such misconduct;

     provided, however, that for purposes of Section 11(b)(i)(D)(2), Cause shall
     not include any one or more of the following: bad judgment, negligence or
     any act or omission believed by the Grantee in good faith to have been in
     or not opposed to the interest of the Company (without intent of the
     Grantee to gain, directly or indirectly, a profit to which the Grantee was
     not legally entitled).

          (E) "Good Reason" means:

              (1) The assignment to the Grantee of any duties inconsistent in
         any respect with the Grantee's position (including status, titles and
         reporting requirement), authority, duties or responsibilities, or any
         other action by the Company that results in a diminution in such
         position, authority, duties or responsibilities, excluding for this
         purpose an isolated, insubstantial and inadvertent action that is not
         taken in bad faith and that is remedied by the Company promptly after
         receipt of written notice thereof given by the Grantee within 30 days
         following the assignment or other action by the Company;

                  (2) Any reduction in compensation; or

              (3) Change in location of office of more than 35 miles without
         prior consent of the Grantee.

     (ii) Dissolution or Liquidation. In the event of the proposed dissolution
or liquidation of the Company, to the extent that an Award is outstanding, it
will terminate immediately prior to the consummation of such proposed action.
The Board may, in the exercise of its sole discretion in such instances, declare
that any Option or SAR shall terminate as of a date fixed by the Board and give
each Grantee the right to exercise his or her Option or SAR as to all or any
part of the Covered Stock, including Shares as to which the Option or SAR would
not otherwise be exercisable.

     (iii) Merger or Asset Sale. Except as otherwise determined by the Board, in
its discretion, prior to the occurrence of a merger of the Company with or into
another corporation, or the sale of substantially all of the assets of the
Company, in the event of such a merger or sale each outstanding Option or SAR
shall be assumed or an equivalent option or right shall be substituted by the
successor corporation or a Parent or Subsidiary of the successor corporation. In
the event that the successor corporation or a Parent or Subsidiary of the
successor corporation does not agree to assume the Option or SAR or to
substitute an equivalent option or right, the Administrator shall, in lieu of
such assumption or substitution, provide for the Grantee to have the right to
exercise the Option or SAR as to all or a portion of the Covered Stock,
including Shares as to which it would not otherwise be exercisable. If the
Administrator makes an Option or SAR exercisable in lieu of assumption or
substitution in the event of a merger or sale of assets, the Administrator shall
notify the Grantee that the Option or SAR shall be fully exercisable for a
period of 15 days from the date of such notice, and the Option or SAR will
terminate upon the expiration of such period. For the purposes of this
paragraph, the Option or SAR shall be considered assumed if, following the
merger or sale of assets, the option or right confers the right to purchase, for
each Share of Covered Stock subject to the Option or SAR immediately prior to
the merger or sale of assets, the consideration (whether stock, cash, or other

                                       12
<PAGE>

securities or property) received in the merger or sale of assets by holders of
Common Stock for each Share held on the effective date of the transaction (and
if holders were offered a choice of consideration, the type of consideration
chosen by the holders of a majority of the outstanding Shares); provided,
however, that if such consideration received in the merger or sale of assets was
not solely common stock of the successor corporation or its Parent, the
Administrator may, with the consent of the successor corporation and the
participant, provide for the consideration to be received upon the exercise of
the Option or SAR, for each Share of Optioned Stock subject to the Option or
SAR, to be solely common stock of the successor corporation or its Parent equal
in Fair Market Value to the per Share consideration received by holders of
Common Stock in the merger or sale of assets.

              (iv) Except as otherwise determined by the Board, in its
         discretion, prior to the occurrence of a Change in Control other than
         the dissolution or liquidation of the Company, a merger of the Company
         with or into another corporation, or the sale of substantially all of
         the assets of the Company, in the event of such a Change in Control,
         all outstanding Options and SARs, to the extent they are exercisable
         and vested (including Options and SARs that shall become exercisable
         and vested pursuant to Section 11 (b) (i) above), shall be terminated
         in exchange for a cash payment equal to the Change in Control Price
         (reduced by the exercise price applicable to such Options or SARs).
         These cash proceeds shall be paid to the Grantee or, in the event of
         death of an Grantee prior to payment, to the estate of the Grantee or
         to a person who acquired the right to exercise the Option or Stock
         Purchase Right by bequest or inheritance.

     12. Term of Plan. The Plan shall become effective upon its approval by the
stockholders of the Company within 12 months after the date the Plan is adopted
by the Board. Such stockholder approval shall be obtained in the manner and to
the degree required under applicable federal and state law. The Plan shall
continue in effect until October 17, 2011, unless terminated earlier under
Section 13 of the Plan.

     13. Amendment and Termination of the Plan.

         (a) Amendment and Termination. The Board may at any time amend, alter,
     suspend or terminate the Plan.

         (b) Stockholder Approval. The Company shall obtain stockholder approval
     of any Plan amendment to the extent necessary and desirable to comply with
     Rule 16b-3 or with Section 422 of the Code (or any successor rule or
     statute or other applicable law, rule or regulation, including the
     requirements of any exchange or quotation system on which the Common Stock
     is listed or quoted). Such stockholder approval, if required, shall be
     obtained in such a manner and to such a degree as is required by the
     applicable law, rule or regulation.

         (c) Effect of Amendment or Termination. No amendment, alteration,
     suspension or termination of the Plan shall impair the rights of any
     Grantee, unless mutually agreed otherwise between the Grantee and the
     Administrator, which agreement must be in writing and signed by the Grantee
     and the Company.

     14. Conditions Upon Issuance of Shares.

         (a) Legal Compliance. Shares shall not be issued pursuant to an Award
     unless the exercise, if applicable, of such Award and the issuance and
     delivery of such Shares shall comply with all relevant provisions of law,
     including, without limitation, the Securities Act of 1933, as amended, the
     Exchange Act, the rules and regulations promulgated thereunder, Applicable
     Law, and the requirements of any stock exchange or quotation system upon
     which the Shares may then be listed or quoted, and shall be further subject
     to the approval of counsel for the Company with respect to such compliance.

         (b) Investment Representations. As a condition to the exercise of an
     Award, the Company may require the person exercising such Award to
     represent and warrant at the time of any such exercise that the Shares are
     being purchased only for investment and without any present intention to
     sell or distribute such Shares if, in the opinion of counsel for the
     Company, such a representation is required

     15. Liability of Company.

         (a) Inability to Obtain Authority. The inability of the Company to
     obtain authority from any regulatory body having jurisdiction, which
     authority is deemed by the Company's counsel to be necessary to the lawful

                                       13
<PAGE>

     issuance and sale of any Shares hereunder, shall relieve the Company of any
     liability in respect of the failure to issue or sell such Shares as to
     which such requisite authority shall not have been obtained.

         (b) Grants Exceeding Allotted Shares. If the Covered Stock covered by
     an Award exceeds, as of the date of grant, the number of Shares that may be
     issued under the Plan without additional stockholder approval, such Award
     shall be void with respect to such excess Covered Stock, unless stockholder
     approval of an amendment sufficiently increasing the number of Shares
     subject to the Plan is timely obtained in accordance with Section 13 of the
     Plan.

     16. Reservation of Shares. The Company, during the term of this Plan, will
at all times reserve and keep available such number of Shares as shall be
sufficient to satisfy the requirements of the Plan.

     17. Rights of Employees and Consultants. Neither the Plan nor any Award
shall confer upon an Grantee any right with respect to continuing the Grantee's
employment or consulting relationship with the Company, nor shall they interfere
in any way with the Grantee's right or the Company's right to terminate such
employment or consulting relationship at any time, with or without cause.

     18. Sub-plans for Foreign Subsidiaries. The Board may adopt sub-plans
applicable to particular foreign Subsidiaries. All Awards granted under such
sub-plans shall be treated as grants under the Plan. The rules of such sub-plans
may take precedence over other provisions of the Plan, with the exception of
Section 3, but unless otherwise superseded by the terms of such sub-plan, the
provisions of the Plan shall govern the operation of such sub-plan.

                                       14
<PAGE>

                       SCHEDULE TO THE JABIL CIRCUIT, INC.

                            2002 STOCK INCENTIVE PLAN

                  (CONSTITUTING THE COMPANY STOCK OPTION PLAN)

      ADOPTED BY THE COMPANY BY RESOLUTION OF THE BOARD ON APRIL 18, 2002,

                     AND APPROVED BY THE INLAND REVENUE ON __

                       (INLAND REVENUE REFERENCE : X22111)

1.       DEFINITIONS AND INTERPRETATION

1.1      In this schedule these words and expressions shall have the following
         meanings:

"Acquiring Company"     where the conditions of paragraph 15 of Schedule 9 are
                        met, such company as shall be at any time the "acquiring
                        company" as defined in that paragraph;

"Adoption Date"         April 18, 2002;

"Associated Company"    the meaning given in Section 187(2) of the Taxes Act;

"Common Stock"          common stock of the Company which satisfies the
                        conditions specified in paragraphs 10 to 14 inclusive of
                        Schedule 9;

"the Company"           Jabil Circuit, Inc., a corporation resident in the
                        United States and incorporated in Delaware;

"Control"               the same meaning as given in Section 840 of the Taxes
                        Act;

"Dealing Day"           any day on which the United States National Stock
                        Exchanges are open for trading;

"Eligible               Employee" any Employee of a Participating
                        Company (provided that in the case of a
                        director, he is required to devote to his
                        duties not less than 25 hours per week
                        (excluding meal breaks)) and is not
                        precluded by paragraph 8 of Schedule 9 from
                        participating in the Plan.

"Market Value"          in relation to a share of Common Stock on any day:

                          -if the Common Stock is admitted to

                                       15
<PAGE>

                        the New York Stock Exchange, its closing sale price (or
                        the closing bid, if no sales  were reported) for the
                        immediately preceding Dealing Day as published in the
                        Wall Street Journal; or

                        if the Common Stock is not admitted to the New York
                        Stock Exchange its market value as determined in
                        accordance with Sections 272 and 273 of the Taxation of
                        Chargeable Gains Act 1992 and agreed on or before that
                        date with Inland Revenue Shares Valuation.

                        For the avoidance of doubt, references in the Plan to
                        "Fair Market Value" shall not apply to Options granted
                        under this schedule.

"New Option"            an Option over Common Stock meeting the requirements of
                        sub-paragraphs 15(3)(a) to (d) of Schedule 9 (but on
                        the basis that the legislation governing the
                        acquisition of shares in the Company is accepted by the
                        Inland Revenue as being directly comparable to a change
                        of control as envisaged in paragraph 15(1) of Schedule
                        9), granted in consideration for the release of a
                        Subsisting Option within the "appropriate period" (as
                        defined by paragraph 15(2) of Schedule 9);

"Option"                a right to acquire Common Stock granted pursuant to
                        Rule 2.2 or Rule 7.2;

"Option Certificate"    the option certificate in the form set out in
                        Appendix II or in such form as the Committee may
                        determine from time to time;

"Participant"           a person who has been granted an Option under this
                        schedule or (where the context admits) his legal
                        personal representative(s);

"Participating Company" the Company and any company which is under the
                        Control of the Company and which the Committee has
                        resolved shall participate in the Plan;

"Plan"                  the Jabil Circuit, Inc. 2002 Stock Incentive Plan;

"Schedule 9"            Schedule 9 to the Taxes Act;

"Subsisting Option"     an Option which has been granted and which has not
                        been lapsed, surrendered, renounced or exercised
                        in full;

"Taxes Act"             the Income and Corporation Taxes Act 1988.

1.2      In the event of any ambiguity or conflict arising between the terms of
         this schedule and those of the Plan, in relation to Options granted
         under this schedule, the terms of this schedule shall prevail as
         between the Participating Companies and Optionees.

2.       GRANT OF OPTIONS

2.1      For the purposes of Options granted under this schedule the powers of
         the Administrator as set out at section 4(b) of the Plan shall not
         apply and section 4(b) of the Plan shall be replaced by paragraphs 2.2
         to 2.11 below.

                                       16
<PAGE>

2.2      Options may be granted by the Committee under this schedule to Eligible
         Employees, with references to Non statutory Stock options in section 6
         of the Plan including Options granted under this schedule, subject to
         the terms and conditions of the Plan as amended by this schedule. For
         the avoidance of doubt, Options granted under this schedule may not be
         granted to "Consultants" as referred to in the Plan.

2.3      For Options granted under this schedule section 6(c) of the Plan shall
         not apply. The Exercise Price of Options granted under this schedule
         shall be determined by the Committee on or prior to the Date of Grant ,
         being not less than the greater of:

         2.3.1    the Market Value of a share of Common Stock on the Date of
                  Grant; and

         2.3.2    the par value of a share of Common Stock;

         but subject to any adjustment made pursuant to paragraph 5 of this
         schedule.

2.4      Any conditions to which an Option granted under this schedule may be
         subject under section 6(d) of the Plan:

         2.4.1    shall be based on such objective terms, conditions and/or
                  provisions as the Committee shall determine PROVIDED THAT the
                  availability for exercise of such an Option at a relevant time
                  is not dependant on the discretion of any person; and

         2.4.2    shall be specified on the Date of Grant and shall be set out
                  in full and enclosed with or endorsed on the Option
                  Certificate.

2.5      Where events happen which cause the Committee to consider that any
         terms, conditions and/or provisions imposed in accordance with section
         6(d) of the Plan no longer represent a fair measure of performance the
         Committee may vary the terms, conditions and/or provisions to the
         extent that it considers appropriate PROVIDED that it reasonably
         considers the terms, conditions and/or provisions as varied or amended
         are no more or less difficult to satisfy and FURTHER PROVIDED THAT the
         Participants are given notice in writing of the variation as soon as
         practicable.

2.6      Options granted under this schedule shall, subject to the other terms
         of this schedule, be subject to the provisions of the Plan and, for the
         avoidance of doubt, shall be taken into account when calculating the
         applicable number of shares of Common Stock for the purpose of section
         3 of the Plan.

2.7      Any Eligible Employee to whom an Option is awarded shall be entitled
         within 14 days of receipt of the corresponding option certificate by
         written notice to the Company to decline to accept the Option and upon
         receipt of such notice by the Company the Option shall lapse.

2.8      Options granted under this schedule may not be transferred in any other
         manner than by will. The provisions under section 5(h) of the Plan
         allowing the transfer of options by other means shall not apply to
         Options granted under this schedule.

2.9      For the avoidance of doubt, references in the Plan to "Incentive Stock
         Options", "Stock Purchase Rights", "Stock Appreciation Rights", "Stock
         Awards", "Performance Units" and "Performance Shares" shall not apply
         to Options granted under this schedule.

2.10     The words "or such other later date as is determined by the
         Administrator" in Section 2(o) shall not apply for the purposes of
         Options granted under this schedule.

2.11     No Option shall be granted under this schedule at a date more than ten
         years from the Adoption Date.

3.       INDIVIDUAL LIMITS

3.1      No Option shall be granted under this schedule to an Eligible Employee
         at any time if it would result in the

                                       17
<PAGE>

         aggregate of the Market Value (calculated on the date when the rights
         were acquired) of all the shares of Common Stock which he may acquire
         on the exercise of any option which has been granted to him under:

         3.1.1    this schedule; and

         3.1.2    any other stock option schemes adopted by the Company or an
                  Associated Company and approved by the Inland Revenue
                  excluding any savings-related stock option scheme approved
                  under Schedule 9;

         exceeding in amount Pound Sterling30,000 PROVIDED THAT no account shall
         be taken of any such options which have been exercised or have lapsed.

3.2      Any Option granted under this schedule to a Participant shall be
         limited and take effect so that it is over the maximum number of shares
         of Common Stock which, when multiplied by the relevant Market Value,
         does not exceed the limits contained in this Rule 3.

3.3      The Market Value of shares shall be calculated as at the time the
         Options in relation to those shares were granted or such earlier time
         as may have been agreed in writing with the Board of Inland Revenue.

4.       EXERCISE OF OPTIONS

4.1      An Option granted under this schedule cannot be exercised if at the
         date of exercise the -Participant is precluded by paragraph 8 of
         Schedule 9 from participation in the Plan.

4.2      For Options granted under this schedule sections 6(e)) and 6(f) of the
         Plan shall not apply. Instead, an Option may be exercised in whole or
         in part (but not for a fraction of a share of Common Stock), by the
         delivery to the Secretary of the Company or his office of:

         4.2.1    a notice of exercise in the form prescribed by the Company
                  duly completed and signed by the Participant (or by his duly
                  authorised agent), stating the number of shares of Common
                  Stock over which the Option is then to be exercised;

         4.2.2    a cheque or cash for the Exercise Price payable in respect of
                  each of the shares of Common Stock over which the Option is to
                  be exercised;

         PROVIDED THAT the Committee may in its discretion allow the exercise of
         an Option in any other manner which is unambiguous and substantially
         equivalent and accompanied by a remittance for the Exercise Price
         payable in respect of the Common Stock over which the Option is
         exercised. For the avoidance of doubt, any alternative manner of
         exercise will be subject to the prior approval of the Inland Revenue.

4.3      Stock to be issued pursuant to the exercise of an Option granted under
         this schedule shall be allotted to the Participant within 30 days
         following the date of effective exercise of the Option.

4.4      References in section 5(f)(i) of the Plan to the exercise of Options by
         persons other than the personal representatives of the Participant's
         estate shall not apply in respect of Options granted under this
         schedule.

4.5      If on exercise of an Option granted under the schedule the Participant
         would be liable to tax, duties or other amounts on such exercise and
         his employer or former employer being the Company, or any Subsidiary
         thereof, is liable to make a payment to the appropriate authorities on
         account of that liability no option shall be exercisable unless, prior
         to the proposed exercise, the Participant shall either:

         4.5.1    grant to the Company the irrevocable authority, as agent of
                  the Participant and on his behalf, to sell or procure the sale
                  of sufficient of the Shares subject to Option so that the net
                  proceeds payable to the Company are so far as possible equal
                  to but not less than the amount payable to the appropriate
                  authorities so that the Company may then pay over the proceeds
                  from the sale to the

                                       18
<PAGE>

                  Participant's employing company and the Participant's
                  employing company shall pay any income tax due on the exercise
                  of the Option and account to the Participant for any balance;
                  or

         4.5.2    make alternative arrangements to the satisfaction of the
                  Company or the Participant's employing company and the Company
                  is informed by the Participant's employing company that the
                  arrangements are satisfactory; or

         4.5.3    pay to the Company or as appropriate the Participant's
                  employing company in Pounds Sterling (whether by cheque or by
                  banker's draft) the amount necessary to satisfy such
                  liabilities.

5.       ADJUSTMENTS TO REFLECT CHANGES IN CAPITAL STRUCTURE

5.1      Section 11(a) of the Plan will not apply to Options granted under this
         schedule at a time when the Plan and this schedule are and are intended
         to remain approved by the Inland Revenue under Schedule 9, in which
         case paragraph 5.2 shall apply.

5.2      Subject to paragraph 5.1, in the event of any capitalisation issue or
         rights issue (which expression shall be deemed to include a variation
         in share capital having an effect similar to a rights issue) or any
         reduction, sub-division or consolidation of share capital of the
         Company by which the rights of the stockholders are altered, the number
         of shares of Common Stock comprised in any Option and/or the Exercise
         Price shall be adjusted by the Committee in such manner as it in its
         absolute discretion determines to be appropriate PROVIDED ALWAYS THAT:

         5.2.1    any such adjustment is subject to the prior written agreement
                  of the Board of Inland Revenue; and

         5.2.2    the Exercise Price shall not be adjusted below the par value
                  of a share of Common Stock.

5.3      The Committee may take such steps as it considers necessary to notify
         Participants of any adjustment made under this paragraph 5 and to call
         in, cancel, endorse or re-issue any Option Certificate consequent on
         such adjustment.

6.       AMENDMENTS TO THE PLAN AND TO OPTIONS

6.1      If any alteration or addition is made at a time when the Plan and this
         schedule are and are intended to remain approved by the Inland Revenue
         under Schedule 9 such alteration or addition shall not have effect
         until it has been approved by the Inland Revenue.

6.2      The words "unless mutually agreed otherwise between the Optionee and
         the Administrator, which agreement must be in writing and signed by the
         Optionee and the Company" in Section 13(c) of the Plan shall not apply
         in respect of Options granted under this Schedule.

6.3      Save for paragraph 3 of this schedule, any amount referred to in this
         Plan shall be in US dollars and any conversion or translation from any
         other currency into US dollars or from US dollars into any other
         currency shall take place at the rates specified by the Committee based
         on the prevailing published exchange rates at the relevant time.

7.       CHANGE OF CONTROL

7.1      Section 5(g) of the Plan shall not apply for the purposes of Options
         granted under this schedule.

7.2      Sections 11(b)(iii) and 11(b)(iv) of the Plan shall be disapplied for
         the purposes of Options granted under this schedule and shall be
         replaced by the following:

         If there is a "Change in Control" of the Company as such expression is
         defined in Section 2(f) of the Plan:

         7.2.1    provided that the circumstances of the "Change in Control" are
                  such that a New Option can be

                                       19
<PAGE>

                  offered, the Participant may, if the Acquiring Company so
                  agrees, release any Option he holds which has been granted
                  under the schedule and in consideration for the grant of a New
                  Option.

                  A New Option issued in consideration of the release of an
                  Option granted under this schedule shall be evidenced by an
                  Option Certificate which shall import the relevant provisions
                  of this schedule.

                  A New Option shall, for all the other purposes of this
                  schedule, be treated as having been acquired at the same time
                  as the corresponding released Option;

         7.2.2    if a participant is not offered a New Option, the
                  Administrator shall, in lieu of the grant of a New Option,
                  provide for the Participant to have the right to exercise his
                  or her Option as to all of the Covered Stock. If the
                  Administrator makes an Option exercisable in lieu of the grant
                  of a New Option, the Administrator shall notify the
                  Participant that the Option shall be fully exercisable for a
                  period of 15 days from the date of such notice and the Option
                  will terminate upon the expiration of such period.

7.3      References to Participating Company shall continue to be construed as
         if references to the Company were references to Jabil Circuit, Inc.

                                       20Exhibit 10.25

                            ASSET PURCHASE AGREEMENT

     THIS AGREEMENT is made May 8, 2001, among OrthoLogic Corp., a Delaware
corporation ("OrthoLogic"), OrthoLogic Canada Ltd., a Canada corporation
("OrthoCanada"; and together with OrthoLogic, "Seller"), OrthoRehab, Inc., a
Delaware corporation ("OrthoRehab") and 2002819 Ontario Limited, a Canada
Corporation ("RehabCanada;" and together with OrthoRehab, "Purchaser").

                                    RECITALS

     A. Seller, through its so-called continuous passive motion division, also
known by Seller as its OrthoRehab division, develops, manufactures and markets
continuous passive motion devices and ancillary orthopedic recovery products.
The business conducted by the division, is herein referred to as the "Division
Business."

     B. Seller desires to sell to Purchaser substantially all of Seller's assets
relating exclusively to the Division Business, and Purchaser desires to purchase
said assets, all on the terms and subject to the conditions contained in this
Agreement.

                                   AGREEMENTS

     Therefore, for good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the parties agree as follows:

                                   ARTICLE 1

                           PURCHASE AND SALE OF ASSETS

     1.1 AGREEMENT TO PURCHASE AND SELL. On the terms and subject to the
conditions contained in this Agreement, Purchaser agrees to purchase from
Seller, and Seller agrees to sell to Purchaser, the assets, properties and
rights as of the Closing Date (as herein defined), wherever situated or located,
of Seller which are used exclusively in or relate exclusively to the conduct of
the Division Business and which are described in Section 1.2 (the "Purchased
Assets"). To the extent that the Schedules required by Section 1.2 require
amendment due to changes in such assets, properties and rights in the Ordinary
Course of Business (as herein defined) as of the Closing the parties shall amend
such Schedules to provide for such changes on the Closing Date, and such
amendments shall be deemed to be a part of this Agreement and incorporated
herein by reference. Without limiting the generality of the foregoing, the
Purchased Assets shall not include any of the assets, properties and rights
described in Section 1.3 (the "Excluded Assets").

     1.2 ENUMERATION OF PURCHASED ASSETS. The Purchased Assets shall consist of
the following assets owned by Seller, except to the extent that any of the
foregoing are also enumerated in Section 1.3 as being Excluded Assets:
<PAGE>
          (a) all inventory held for use exclusively in the conduct of the
Division Business (including, without limitation, raw materials, work in
process, finished goods, service parts and supplies) as listed on SCHEDULE
1.2(A);

          (b) all furniture, art work, fixtures, equipment (including office
equipment), machinery, parts, computer hardware, tools, dies, jigs, patterns,
molds, automobiles and trucks and all other tangible personal property (other
than inventory) (the "Tangible Personal Property") used exclusively in the
conduct of the Division Business, including but not limited to those listed on
SCHEDULE 1.2(B);

          (c) all leasehold interests and leasehold improvements created by all
leases listed on SCHEDULE 1.2(C), including, without limitation, capitalized
leases, of personal property used exclusively in connection with the Division
Business under which Seller is a lessee or lessor;

          (d) Seller's entire leasehold interest as lessee of real property
under those leases listed on SCHEDULE 1.2(D) (the "Leased Premises"); provided,
however, that Purchaser shall be entitled to amend such Schedule 1.2(d) in its
sole discretion prior to the Closing Date to exclude any such leases, and any
such amendment shall be deemed to be a part of this Agreement and incorporated
herein by reference; provided further, that, subject to Section 6.2(i), the
lease between Seller and TMC (Heritage) Corp. dated September 1998 for the lease
of Seller's Pickering, Ontario, Canada location shall not be excluded by such
amendment;

          (e) all of the so-called "work in process" accounts receivable listed
on SCHEDULE 1.2(E), as shown on the Pro Forma Balance Sheet (as herein defined),
with such changes from the date of the Pro Forma Balance Sheet until the Closing
Date as are in the Ordinary Course of Business (as herein defined) (the
"Purchased Receivables"). The dollar amount of the Purchased Receivables shall
be defined herein as the "Purchased Receivables Amount". Such Purchased
Receivables shall include the following, and shall exclude any Medicare/Medicaid
receivables:

               (i) an account receivable billable to a Payor (as defined in
Section 4.3), arising from the provision of health care services (and any
services or sales ancillary thereto) by the Division Business including the
right to payment of any interest or finance charges and other obligations of
such Payor with respect thereto;

               (ii) a health-care-insurance receivable billable to a Payor
arising from the provision of health care services (and any services or sales
ancillary thereto) by the Division Business including the right to payment of
any interest or finance charges and other obligations of such Payor with respect
thereto;

               (iii) all security interests or liens and property subject
thereto from time to time purporting to secure payment by the Payor;

               (iv) all guarantees, indemnities and warranties and proceeds
thereof, proceeds of insurance policies, UCC financing statements (or similar
financing statements under the personal property security legislation of various
Canadian provinces) and other agreements or arrangements of whatever character
from time to time supporting or securing payment of such Purchased Receivable;
<PAGE>
               (v) all Collections (as defined in Section 4.3) with respect to
any of the foregoing;

               (vi) all Records (as defined in Section 4.3) with respect to any
of the foregoing; and

               (vii) all proceeds of any of the foregoing;

          (f) the so-called "rental fleet" listed on SCHEDULE 1.2(F);

          (g) notes receivable, negotiable instruments and chattel paper
received as a result of the conduct of the Division Business;

          (h) all deposits and rights with respect thereto exclusively in
connection with the Division Business;

          (i) subject to Section 8.7, all contracts listed on SCHEDULE 1.2(I),
or portions thereof, (and benefits arising therefrom) to the extent that they
relate to or arise exclusively out of the Division Business (provided that the
non-compete agreements with the Division Business employees shall be assigned
only to the extent that they relate to the Division Business), all rights
against suppliers under warranties covering any of the tangible assets of the
Division Business and all Permits (as herein defined) and Environmental Permits
(as herein defined);

          (j) all sales orders, purchase orders, quotations and bids generated
by the operation of the Division Business listed on SCHEDULE 1.2(J);

          (k) the Intellectual Property (as herein defined) and all goodwill
associated with such Intellectual Property; including but not limited to that
listed on SCHEDULE 1.2(K);

          (l) subject to Section 8.7, all license agreements, distribution
agreements, sales representative agreements, service agreements, supply
agreements, franchise agreements, computer software agreements and technical
service agreements relating exclusively to the Division Business listed on
SCHEDULE 1.2(L);

          (m) all customer lists, customer records and information relating
exclusively to the Division Business;

          (n) all books and records relating exclusively to the Division
Business, including, without limitation, blueprints, drawings and other
technical papers, payroll, employee benefit, accounts receivable (except with
respect to Retained Receivables (as herein defined)) and payable, inventory,
maintenance, and asset history records, ledgers, and books of original entry,
all insurance records and OSHA and EPA files;

          (o) all rights in connection with prepaid expenses with respect to the
Purchased Assets;
<PAGE>
          (p) all letters of credit issued to Seller relating exclusively to the
Division Business;

          (q) all computer software relating exclusively to, or used exclusively
by, the Division Business, including all documentation and source codes with
respect to such software and, subject to Section 8.7, all licenses of software,
including but not limited to that set forth on SCHEDULE 1.2(Q);

          (r) all sales and promotional materials, catalogues and advertising
literature relating exclusively to the Division Business;

          (s) all telephone and fax numbers relating exclusively to the Division
Business;

          (t) all franchises, permits, certificates, approvals and licenses and
other governmental authorizations and accreditations held by the Seller
exclusively related to ownership and operation of the Division Business to the
extent transferable, as described in SCHEDULE 1.2(T) attached hereto;

          (u) copies of all financial, accounting and other business records of
the Seller of any type or description relating exclusively to the Division
Business;

          (v) any of Seller's right, title and interest in and to records of
identity, diagnosis, evaluation or treatment of patients relating exclusively to
the Division Business; and

          (w) any other tangible and intangible property of the Seller necessary
for, and exclusively related to, the operation of the Division Business.

As used in this Agreement, "Ordinary Course of Business" means that an action
taken by a Person (as herein defined) will be deemed to have been taken in the
"Ordinary Course of Business" only if: (i) such action is consistent with the
past practices of such Person and is taken in the ordinary course of the normal
day-to-day operations of such Person; (ii) such action is not required to be
authorized by the board of directors of such Person (or by any Person or group
of Persons exercising similar authority) and is not required to be specifically
authorized by the parent company (if any) of such Person; and (iii) such action
is similar in nature and magnitude to actions customarily taken, without any
authorization by the board of directors (or by any Person or group of Persons
exercising similar authority), in the ordinary course of day-to-day operations
of other Persons that are in the same line of business as such Person.

     1.3 EXCLUDED ASSETS. The Excluded Assets shall consist of all assets,
properties and rights not enumerated as Purchased Assets in Section 1.2,
including, without limitation, the following items:

          (a) all cash on hand and in banks, cash equivalents (exclusive of
letters of credit issued by customers of Seller) and investments;

          (b) Seller's bank accounts, lock box accounts (except as governed by
the Lockbox Agreement, as defined below), checkbooks and cancelled checks;
<PAGE>
          (c) all accounts receivable other than the Purchased Receivables (the
"Retained Receivables");

          (d) Seller's rights under the non-compete agreements with the Division
employees to the extent that they relate to Seller's business other than the
Division Business, and those contracts with Seller's Affiliates (as herein
defined) set forth on SCHEDULE 1.3(D) hereto;

          (e) rights in and to claims and litigation (and in each case benefits
to the extent they arise therefrom) against third parties to the extent such
claims and litigation are not in any way related to the Purchased Assets or the
Assumed liabilities (as herein defined), and rights in and to claims (and
benefits to the extent they arise therefrom) that relate to Excluded Liabilities
(as herein defined);

          (f) insurance policies of Seller and rights in connection therewith;

          (g) rights arising from prepaid expenses, if any, with respect to
assets not being sold hereunder;

          (h) rights arising from any refunds due with respect to insurance
premium payments and refunds due from federal, state, provincial and/or local
taxing authorities with respect to taxes heretofore paid by Seller;

          (i) deposits of Seller with the Internal Revenue Service and Canada
Customs and Revenue Agency, including, without limitation, tax deposits,
prepayments and estimated payments;

          (j) all rights of indemnification, claims and causes of action which
relate to the conduct of the Division Business prior to the Closing Date,
including, without limitation, those against any person under any purchase or
other agreement pursuant to which Seller or any of its Affiliates acquired any
portion of the Division Business or those arising by operation of law or equity
or otherwise, but excluding product warranty claims with respect to tangible
assets of the Division Business against the suppliers thereof;

          (k) Seller's rights under this Agreement;

          (l) Seller's corporate charter, minute and stock record books, and
corporate seal and tax returns;

          (m) the agreements set forth on SCHEDULE 1.3(M);

          (n) the assets, if any, described on SCHEDULE 1.3(N);

          (o) all assets and properties of Seller used, but not exclusively, in
the conduct of Division Business, including, without limitation, the names
"OrthoLogic" and "OrthoLogic Canada" and all intellectual property rights of
Seller with respect to such names;
<PAGE>
          (p) all franchises, permits, certificates, approvals and licenses and
other governmental authorizations and accreditations held by Seller not
specifically transferred to Purchaser; and

          (q) any contracts, agreements, leases and commitments of Seller not
otherwise described in Section 1.2 hereof.

                                   ARTICLE 2

                            ASSUMPTION OF LIABILITIES

     2.1 AGREEMENT TO ASSUME. At the Closing (as herein defined), Purchaser
shall assume and agree to discharge and perform when due, the liabilities and
obligations of Seller with respect to the Division Business which are described
in Section 2.2 (the "Assumed Liabilities"). All Assumed Liabilities referred to
in Sections 2.2(a) and 2.2(b) shall be specifically listed on SCHEDULE
2.2(a)/(b) and shall not exceed $4,600,000. To the extent that the Schedules
required by Section 2.2 require amendment due to changes in such liabilities and
obligation in the Ordinary Course of Business as of the Closing the parties
shall amend such Schedules to provide for such changes on the Closing Date, and
such amendments shall be deemed to be a part of this Agreement and incorporated
herein by reference. All liabilities and obligations of Seller enumerated in
Section 2.3 are collectively referred to herein as "Excluded Liabilities."
Seller shall remain liable for the Excluded Liabilities.

     2.2 DESCRIPTION OF ASSUMED LIABILITIES. The Assumed Liabilities shall
consist of the following, and only the following, liabilities of Seller with
respect to the Division Business:

          (a) all trade accounts payable as of the Closing Date as set forth on
the Pro Forma Balance Sheet, with such changes from the date of the Pro Forma
Balance Sheet until the Closing Date as are in the Ordinary Course of Business;

          (b) all accrued and unpaid expenses as of the Closing Date as set
forth on the Pro Forma Balance Sheet, including, without limitation, accrued
salaries, wages and vacation pay, and taxes with respect thereto, with respect
to those employees of Seller who become employees of Purchaser immediately after
the Closing shown on such Pro Forma Balance Sheet, with such changes from the
date of the Pro Forma Balance Sheet until the Closing Date as are in the
Ordinary Course of Business;

          (c) all liabilities and obligations of Seller, whether or not
reflected on the Pro Forma Balance Sheet, under any purchase order, sales order,
lease, license, agency and distributorship agreement or other agreement or
commitment of any kind, or portion thereof, with respect to the Division
Business, listed on Schedule 2.2(c), which is assigned to and specifically
accepted by Purchaser pursuant to any provision of this Agreement, excluding any
claim, dispute or other liability or obligation for breach of any such
agreements arising or accruing prior to the Closing, and excluding any payment
due, performance obligation, or other liability or obligation under any such
agreements arising or accruing prior to the Closing (unless otherwise enumerated
as an Assumed Liability in Section 2.2(a) or 2.2(b) above.); and
<PAGE>
          (d) all liabilities and obligations of Seller, whether or not
reflected on the Pro Forma Balance Sheet, under any Permits and Environmental
Permits, governmental approvals, provider numbers or billing numbers, listed on
Schedule 2.2(d) which are assigned or transferred to and specifically accepted
by Purchaser pursuant to any provision of this Agreement.

     2.3 EXCLUDED LIABILITIES. Except for those specifically contemplated by
Section 2.2 hereof, Purchaser will not assume or perform any liabilities or
obligations of Seller of any kind, whether disclosed or undisclosed, arising or
accruing on or before the Closing Date, whether accrued, absolute, contingent or
otherwise, including but not limited to any of the following obligations and
liabilities, all or any of which shall constitute Excluded Liabilities and shall
not be assumed or discharged by Purchaser:

          (a) any liabilities for legal, accounting, audit and investment
banking fees, brokerage commissions, and any other like expenses incurred by
Seller in connection with the negotiation and preparation of this Agreement and
the sale of the Purchased Assets to Purchaser;

          (b) any liabilities of Seller for (i) taxes on or measured by income,
(ii) franchise taxes, (iii)any other tax or withholding obligation, with respect
to the Division Business or otherwise, accruing or arising prior to the Closing,
or (iv)ERICA obligations;

          (c) any liabilities for or related to indebtedness of Seller to banks
or other financial institutions with respect to borrowed money;

          (d) any liabilities of Seller under those leases, contracts, insurance
policies, commitments, sales orders, purchase orders, governmental approvals,
provider or billing numbers, Permits and Environmental Permits or portions
thereof which are not assigned to Purchaser pursuant to the provisions of this
Agreement;

          (e) any liability or obligation pursuant to any dispute, claim,
controversy, action, suit, proceeding, charge, hearing , investigation or
settlement accruing or arising, prior to the Closing, including but not limited
to any liability or obligation of Seller or the Division Business arising as a
result of any legal or equitable action or judicial or administrative proceeding
initiated at any time in respect of anything done, suffered, to be done or
omitted on or prior to the Closing Date by Seller or any of Seller's employees
or agents, including without limitation, any liability or obligation of Seller
or the Division Business with respect to any malpractice claims, actions,
proceedings or settlements or with respect to reimbursement from any third party
payer including any governmental payer (including but not limited to those
listed in the Disclosure Schedule) and any liability or obligation of Seller or
the Division Business with respect to design or manufacturing defects in the
Products;

          (f) any liability with respect to employees, agents, independent
contractors or similarly situated person accruing or arising prior to the
Closing Date or pursuant to Section 9.2, unless specifically enumerated as an
Assumed Liability; and

          (g) without limitation by the specific enumeration of the foregoing,
any liabilities not expressly assumed by Purchaser pursuant to the provisions of
Section 2.2.
<PAGE>
                                   ARTICLE 3

                  PURCHASE PRICE. MANNER OF PAYMENT AND CLOSING

     3.1 PURCHASE PRICE. The "Purchase Price" of the Purchased Assets shall be
the Cash Portion (as defined below) plus any Contingent Payment Amount (as
defined below) plus the aggregate book amount of the Assumed Liabilities.

     3.2 TIME AND PLACE OF CLOSING. The transaction contemplated by this
Agreement shall be consummated (the "Closing") at 10:00 a.m. at the offices of
Gatsby Hannah LLP, 225 Franklin Street, Boston, Massachusetts on the thirtieth
(30th) day following the date of this Agreement, or on such other date, or at
such other time or place, as shall be mutually agreed upon by Seller and
Purchaser; provided, however, that the date of the Closing shall be
automatically extended from time to time for so long as any of the conditions
set forth in Article VI shall not be satisfied or waived, subject, however, to
the provisions of Section 11.2. The date on which the Closing occurs in
accordance with the preceding sentence is referred to in this Agreement as the
"Closing Date". The Closing shall be deemed to be effective as of 12:01 a.m.
Eastern Standard Time on the Closing Date.

     3.3 MANNER OF PAYMENT OF THE PURCHASE PRICE. At the Closing:

          (a) Purchaser shall assume the Assumed Liabilities;

          (b) Purchaser shall pay $12,500,000 (the "Cash Portion") to Seller, by
wire transfer to such account as Seller shall designate by written notice
delivered to Purchaser on or prior to the Closing Date; and

          (c) ON THE DATE WHICH IS 390 DAYS AFTER THE CLOSING DATE, PURCHASER
SHALL PAY AN ADDITIONAL CONTINGENT PAYMENT EQUAL TO THE LESSER OF (i) ANY
AMOUNTS COLLECTED BY PURCHASER FROM THE PURCHASED RECEIVABLES IN EXCESS OF 50%
OF THE NET PURCHASED RECEIVABLES AMOUNT OR (ii) $2,500,000 (THE "CONTINGENT
PAYMENT AMOUNT").

     3.4 ALLOCATION OF PURCHASE PRICE FOR UNITED STATES. The Purchase Price in
respect of the assets being purchased by OrthoRehab shall be allocated among the
Purchased Assets in the manner required by Section l060 of the Code (as herein
defined) and in accordance with a mutually agreed upon schedule with respect to
the same to be delivered by the parties at the Closing (the "Allocation of
Purchase Price Schedule for the United States").

     3.5 ALLOCATION OF PURCHASE PRICE FOR CANADA. The Purchase Price in respect
of the Purchased Assets being purchased by RehabCanada shall be allocated among
the Purchased Assets in the manner set forth in a mutually agreed upon schedule
with respect to the same to be delivered by the parties at the Closing (the
"Allocation of Purchase Price Schedule for Canada"). Such allocation shall be
binding and the Seller and the Purchaser shall file all filings which are
necessary or desirable under the Income Tax Act (Canada) or any other taxation
statute to give effect to such allocation.
<PAGE>
     Notwithstanding the foregoing Sections 3.4 and 3.5, nothing in this
Agreement shall be construed to mean that a party hereto or other person must:

          (a) use, for any one or more purposes, any price or other allocation
set forth or provided for in this Agreement if such party or person reasonably
believes or reasonably is advised that such use is not in accordance with law;
or

          (b) make or file, or cooperate in the making or filing of, any return
or report to any governmental authority in any manner that such party or person
reasonably believes or is reasonably advised is not in accordance with law.

          The Allocation of Purchase Price Schedule for the United States and
the Allocation of Purchase Price Schedule for Canada to be delivered by the
parties hereto at Closing shall collectively be referred to herein as the
"Allocation Schedules".

     3.6 CLOSING PRO FORMA BALANCE SHEET. Within ten (10) business days after
the Closing Date, Purchaser and Seller shall jointly prepare a mutually
acceptable revised pro forma balance sheet of the Division Business as of the
Closing Date which shall reflect changes in the Ordinary Course of Business from
the date of the Pro Forma Balance Sheet to the Closing Date (the "Closing Pro
Forma Balance Sheet"). The Closing Pro Forma Balance Sheet shall be prepared in
accordance with United States generally accepted accounting principles ("GAAP"),
consistently applied, except (i)as disclosed therein, (ii)for normal year end
adjustments and (iii)for the omission of footnote disclosures required by GAAP.
Upon completion of the Closing Pro Forma Balance Sheet in accordance with this
Section 3.5, the term "Pro Forma Balance Sheet" as used in Articles I and II of
this Agreement shall mean the "Closing Pro Forma Balance Sheet."

                                   ARTICLE 4

                         REPRESENTATIONS AND WARRANTIES

     4.1 GENERAL STATEMENT. The parties make the representations and warranties
to each other which are set forth in this Article IV. All such representations
and warranties shall survive the Closing (and none shall merge into any
instrument of conveyance). All representations and warranties of Seller are made
subject to the exceptions which are noted in the schedule delivered by Seller to
Purchaser concurrently herewith and identified by the parties as the "Disclosure
Schedule." References herein to "Year End Financial Statements" shall mean the
Seller's fiscal year end financial statements dated December 31, 2000 provided
to Purchaser.

     4.2 PURCHASER'S REPRESENTATIONS AND WARRANTIES. Each Purchaser represents
and warrants to Seller that:

          (a) Purchaser is a corporation duly organized, existing and in good
standing, under the laws of its state or other jurisdiction of incorporation.
<PAGE>
          (b) Purchaser has full corporate power and authority to enter into and
perform (i) this Agreement and (ii) all documents and instruments to be executed
by Purchaser pursuant to this Agreement (collectively, "Purchaser's Ancillary
Documents"). All corporate and other actions or proceedings to be taken by or on
the part of the Purchaser to authorize and permit the execution and delivery by
Purchaser of this Agreement and the instruments required to be executed and
delivered by Purchaser pursuant hereto, the performance by Purchaser of its
obligations hereunder, and the consummation by Purchaser of the transactions
contemplated herein, have been duly and properly taken. This Agreement has been
duly executed and delivered by the Purchaser and constitutes the legal, valid
and binding obligation the Purchaser, enforceable in accordance with its terms
and conditions.

          (c) No consent, authorization, order or approval of, or filing or
registration with, any governmental authority is required for the execution and
delivery by the Purchaser of this Agreement and Purchaser's Ancillary Documents,
and the consummation by Purchaser of the transactions contemplated by this
Agreement and Purchaser's Ancillary Documents.

          (d) Neither the execution and delivery of this Agreement and
Purchaser's Ancillary Documents by Purchaser, nor the consummation by Purchaser
of the transactions contemplated hereby, will conflict with or result in a
breach of any of the terms, conditions or provisions of Purchaser's Certificate
of Incorporation or By-laws or of any statute or administrative regulation to
which either Purchaser is subject, or of any order, writ, injunction, judgment
or decree of any court or governmental authority known to Purchaser to which
such party is bound or subject.

          (e) Purchaser is not a party to any unexpired, undischarged or
unsatisfied written contract, agreement, indenture, mortgage, debenture, note or
other instrument under the terms of which performance by Purchaser according to
the terms of this Agreement will be a material default or event of acceleration,
or grounds for immediate termination, or whereby timely performance by Purchaser
according to the terms of this Agreement may be prohibited.

          (f) Neither Purchaser nor any of its Affiliates has knowledge of any
person or entity who is entitled to a broker's commission, finder's fee,
investment banker's fee or similar payment from Seller for arranging the
transaction contemplated hereby or introducing the parties to each other. As
used in this Agreement, an "Affiliate" means, as to any person, any other person
that, directly or indirectly, is in control of, is controlled by, or is under
common control with, such person within the meaning of control under Section 15
of the Securities Act of 1933.

     4.3 SELLER'S REPRESENTATIONS AND WARRANTIES. Seller represents and warrants
to Purchaser that, except as set forth in the Disclosure Schedule:

          CORPORATE

          (a) Each of OrthoLogic and OrthoCanada is a corporation duly
organized, existing and in good standing, under the laws of its jurisdiction of
incorporation. Each of OrthoLogic and OrthoCanada has all necessary corporate
power and authority to conduct the Division Business as the Division Business is
now being conducted.
<PAGE>
          (b) Each of OrthoLogic and OrthoCanada has qualified as a foreign or
extra-provincial corporation, and is in good standing, under the laws of all
jurisdictions where the nature of the Division Business or the nature or
location of its assets which are used in the Division Business requires such
qualification and where the failure to so qualify would have a Material Adverse
Effect (as herein defined). For the purposes of this Agreement, "Material
Adverse Effect" means any material adverse effect on the assets, properties,
prospects, and financial condition of the Division Business, in whole or in
part.

          (c) Each of OrthoLogic and OrthoCanada has full corporate power and
authority to enter into and perform (i) this Agreement and (ii) all documents
and instruments to be executed by Seller pursuant to this Agreement
(collectively, "Seller's Ancillary Documents"). All corporate and other actions
or proceedings to be taken by or on the part of the Seller to authorize and
permit the execution and delivery by Seller of this Agreement and the
instruments required to be executed and delivered by Seller pursuant hereto, the
performance by Seller of its obligations hereunder, and the consummation by
Seller of the transactions contemplated herein, have been duly and properly
taken. This Agreement has been duly executed and delivered by the Seller and
constitutes the legal, valid and binding obligation the Seller, enforceable in
accordance with its terms and conditions. The Seller has the power and authority
to own and convey all of its properties and assets and to execute and deliver
this Agreement and to perform the transactions contemplated hereby and thereby.
This Agreement constitutes a valid transfer, assignment, set-over and conveyance
to the Purchaser of all right, title and interest of the Seller in and to the
Purchased Assets (including but not limited to the Purchased Receivables) now
existing and hereafter created.

          (d) No consent, authorization, order or approval of, or filing or
registration with, any governmental authority is required for the execution and
delivery and performance of this Agreement and Seller's Ancillary Documents and
the consummation by Seller of the transaction contemplated by this Agreement and
Seller's Ancillary Documents.

          (e) Neither the execution and the delivery of this Agreement, nor the
consummation of the transactions contemplated hereby will (i) violate any
constitution, statute, regulation, rule, injunction, judgment, order, decree,
ruling, charge, or other restriction of any government, governmental agency, or
court to which the Seller is subject or any provision of the charter or by-laws
of the Seller or (ii) conflict with, result in a breach of, constitute a default
under, result in the acceleration of, create in any party the right to
accelerate, terminate, modify, or cancel, or require any notice under any
agreement, contract, lease, license, instrument, or other arrangement to which
the Seller is a party or by which it is bound or to which any of its assets is
subject (or result in the imposition of any lien upon any of their assets).

          (f) OrthoCanada is not a non-resident of Canada within the meaning of
the Income Tax Act (Canada).

          FINANCIAL

          (g) Copies of the pro forma balance sheet of the Division Business
(the "Pro Forma Balance Sheet") as of April 23, 2001, and copies of the Year End
Financial Statements are contained in the Disclosure Schedule. The Pro Forma
Balance Sheet and the Year End Financial Statements are correct and complete and
<PAGE>
consistent with the books and records of Seller and present fairly the financial
position of the Division Business as of the date thereof, in accordance with
GAAP, consistently applied, except (i) as disclosed therein; (ii) for normal
year-end adjustments; (iii)adjustments made on the Closing Pro Forma Balance
Sheet; and (iv)for the omission of footnote disclosures required by GAAP.

          (h) Since December 31, 2000, Seller has not incurred any liabilities
or obligations (whether absolute, accrued, contingent or otherwise) with respect
to the Division Business, except (i) liabilities incurred in the Ordinary Course
of Business and (ii) liabilities incurred in connection with or as a result of
this Agreement and the transactions contemplated hereby.

          (i) The Seller has good and marketable title to, or a valid leasehold
interest in, the properties and assets used by the Division Business, located on
its premises, or shown on the Pro Forma Balance Sheet, free and clear of all
liens. Without limiting the generality of the foregoing, the Seller has good and
marketable title to all of the Purchased Assets, free and clear of any lien or
restriction on transfer.

          (j) (i) For purposes of this Agreement, the term "Taxes" means all
Federal, state, provincial, local, foreign and other income, sales, use, ad
valorum, transfer or other taxes, fees, assessments or charges of any kind,
together with any interest and any penalties with respect thereto, and the term
"Tax" means any one of the foregoing Taxes; the term "Code" means the Internal
Revenue Code of 1986, as amended and the term "ITA" means the Income Tax Act
(Canada), as amended (all citations to the Code, or to the Treasury Regulations
promulgated thereunder, or to the ITA, as applicable, shall include any
amendments or any substitute or successor provisions thereto). "Tax Return"
means any return, declaration, report, claim for refund, or information return
or statement relating to Taxes, including any schedule or attachment thereto,
and including any amendment thereof.

               (ii) Except as set forth in the Disclosure Schedule, (a)all Tax
Returns that were required to be filed with respect to the Division Business
have been filed; (b)all such Tax Returns were correct and complete; (c)all Taxes
owed with respect to the Division Business (whether or not shown on any Tax
Return) have been paid; (d)all Taxes required to have been withheld and paid
with respect to the Division Business in connection with the amounts paid or
owing to any employee, independent contractor, creditor, stockholder or other
third party have been withheld and paid; (e)no notice has ever been received
from an authority in a jurisdiction where Tax Returns are not filed with respect
to the Division Business that such jurisdiction may impose Taxes with respect to
the Division Business or that such jurisdiction is asserting that a Tax Return
must be filed with it; (f) no statute of limitations has ever been waived in
respect to Taxes relating to the Division Business, and no extension of time or
waiver has ever been agreed to with respect to a Tax assessment or deficiency
relating to the Division Business; (g) no federal, state, provincial, local, and
foreign income Tax Returns with respect to the Division Business have been
audited for taxable periods ended on or before Pro Forma Balance Sheet Date; (h)
there is no pending dispute, audit, investigation, proceeding or claim
concerning any liability for Taxes with respect to the Division Business; and
(i) there are no liens or other encumbrances on any of the assets of the
Division Business that arose in connection with any failure (or alleged failure)
<PAGE>
to pay any Tax. As of the date first above written, the Seller's Federal Tax
Identification Number is as set forth on the Disclosure Schedule.

          CONDUCT OF BUSINESS

          (k) Since December 31, 2000, with respect to the Division Business
there has not been:

               (i) any sale, lease, transfer, or assignment of assets, tangible
or intangible, other than (A)sales of inventory for a fair consideration in the
Ordinary Course of Business and (B)cash applied in payment of Seller's
liabilities in the Ordinary Course of Business;

               (ii) any agreement, contract, lease, or license (or series of
related agreements, contracts, leases, and licenses) entered into other than in
the Ordinary Course of Business and in an amount in excess of $25,000;

               (iii) any acceleration, termination, modification, or
cancellation of any agreement, contract, lease, or license or other governmental
approval or accreditation (or series of related agreements, contracts, leases,
and licenses, approvals or accreditations) involving payments of more than
$25,000 to which the Seller is a party or by which it is bound;

               (iv) creation or imposition of any lien upon any assets, tangible
or intangible;

               (v) any capital expenditure (or series of related capital
expenditures) involving more than $10,000 singly or $50,000 in the aggregate or
outside the Ordinary Course of Business;

               (vi) capital investment in, any loan to, or any acquisition of
the securities or assets of, any other person or entity (or series of related
capital investments, loans, and acquisitions) involving payments of more than
$25,000 or outside the Ordinary Course of Business;

               (vii) issuance of any note, bond, or other debt security or the
creation, incurring, assumption, or guarantee of any indebtedness for borrowed
money or capitalized lease obligation involving payments of more than $15,000
singly or $50,000 in the aggregate;

               (viii) any delay or postponement of payment of accounts payable
and other liabilities outside the Ordinary Course of Business;

               (ix) any cancellation, compromise, waiver, or release of any
right or claim or indebtedness (or series of related rights and claims)
involving payments of more than $25,000 or outside the Ordinary Course of
Business;

               (x) grant of any license or sublicense of any rights or
modification of any rights under or with respect to, or entered into any
settlement regarding any infringement of its rights to, any Intellectual
Property;
<PAGE>
               (xi) any reason for the Seller to believe that any major vendors,
licensors, distributors, third party payors, governmental programs, health care
providers, practitioners and customers do not intend to continue with Purchaser
a business relationship on terms at least as favorable as the relationship such
vendors, licensors, distributors payors, programs, providers, practitioners and
customers, as the case may be, currently have with the Division Business;

               (xii) any suppliers that have terminated or, to knowledge of
Seller, intend to terminate or are considering terminating their respective
business relationships or have modified or, to knowledge of Seller, intend to
modify such relationships with the Division Business in a manner which is less
favorable to the Division Business or have agreed not to or will not agree to do
business on such terms and subject to conditions at least as favorable as the
terms and conditions as provided to the Division Business on the date of the
Year End Financial Statements and the Seller has no knowledge of any facts which
would form the basis for such termination or modification or any threat or
notification, orally or in writing of the foregoing;

               (xiii) any damage, destruction, or loss (whether or not covered
by insurance) to property used in the Division Business;

               (xiv) any loan to, or any other transaction with, any directors,
officers and employees of the Seller outside the Ordinary Course of Business;

               (xv) any employment contract or collective bargaining agreement
entered into, written or oral, or modification of the terms of any existing such
contract or agreement except for routine hiring and termination of employees in
the Ordinary Course of Business;

               (xvi) any increase, modification or change in the compensation or
benefits of any of the directors, officers, and employees outside the Ordinary
Course of Business;

               (xvii) any adoption, amendment, modification or termination of
any employee plan or other plan, contract, or commitment for the benefit of any
director, officer or employee of the Seller (or taken any such action with
respect to any other employee plan);

               (xviii) any modification or change in the employment terms for
any of the directors, officers and employees or any offer of employment outside
the Ordinary Course of Business;

               (xix) any charitable or other capital contribution outside the
Ordinary Course of Business or any pledge to make such a contribution;

               (xx) any payment of any amount to any third party with respect to
any liability or obligation (including any costs and expenses the Seller has
incurred or may incur in connection with this Agreement and the transactions
contemplated hereby) which would not constitute an Assumed Liability if in
existence as of the Closing;

               (xxi) any modification or change in the application of GAAP from
the manner in which it was applied in the Year End Financial Statements;
<PAGE>
               (xxii) any other occurrence, event, incident, action, failure to
act, or transaction outside the Ordinary Course of Business; or

               (xxiii) any commitment to any of the foregoing.

          CONTRACTS

          (l) The Disclosure Schedule lists the following contracts and other
agreements to which the Seller or the Division Business is a party in connection
with the Division Business:

               (i) any contract for the employment for any period of time
whatsoever, or in regard to the employment, or restricting the employment, of
any employee of Seller who is employed in the conduct of the Division Business;

               (ii) any consulting agreement pertaining to the conduct of the
Division Business;

               (iii) any collective bargaining agreement covering employees
employed in the conduct of the Division Business;

               (iv) any plan or contract or arrangement providing for bonuses,
incentives, options, shares, compensation or deferred compensation, pension or
retirement payments, profit sharing, medical, hospitalization, drug and dental
benefits, life or accident insurance, disability payments, supplemental
unemployment benefits, accelerated or other severance or termination
entitlements upon change in control or the like, covering employees employed in
the conduct of the Division Business;

               (v) any contract or agreement restricting in any manner the
Division Business' right to compete with any other person or entity, restricting
the Division Business' right to sell to or purchase from any other person or to
employ any person, or restricting the right of any other party to compete with
the Division Business or the ability of such person or entity to employ any of
Seller's employees employed in the conduct of the Division Business;

               (vi) any contract between Seller and any of its Affiliates with
respect to the purchase of goods or the performance of services relating to the
Division Business;

               (vii) any contract of agency, representation, distribution, or
franchise relating to the Division Business which cannot be cancelled by Seller
without payment or penalty upon notice of sixty (60) days or less;

               (viii) any service contract affecting any of the Purchased Assets
where the annual service charge is in excess of $5,000 or has an unexpired term
as of the Closing Date in excess of one year;

               (ix) any guaranty, performance, bid or completion bond, or surety
or indemnification agreement with respect to the Division Business;
<PAGE>
               (x) any lease or sublease with respect to the Division Business,
either as lessee or sublessee, lessor or sublessor, of real or personal property
or intangibles to be assigned to Purchaser pursuant to this Agreement, where the
lease or sublease provides for an annual rent in excess of $10,000 and has an
unexpired term as of the Closing Date in excess of one year;

               (xi) any other contract related to the Division Business which is
to be assigned to Purchaser under this Agreement and which provides for the
receipt or expenditure by Purchaser after such assignment of more than $5,000,
except contracts for the purchase or sale of goods or the rendering of services
in the Ordinary Course of Business.

               (xii) any agreement (or group of related agreements) for the
lease of personal property to or from any person or entity providing for lease
payments in excess of $25,000;

               (xiii) any agreement concerning a partnership or joint venture;

               (xiv) any agreement (or group of related agreements) under which
the Seller has created, incurred, assumed, or guaranteed any indebtedness in
excess of $10,000 or under which it has imposed a lien on any of its assets,
tangible or intangible;

               (xv) any agreement solely between the Seller and its
subsidiaries;

               (xvi) any agreement under which the Seller has advanced or loaned
any amount to any of the directors, officers, or employees of the Seller and its
subsidiaries other than in the Ordinary Course of Business;

               (xvii) any agreement under which the consequences of a default or
termination could have a material effect on the business, financial condition,
operations, results of operations, or future prospects of the Division Business;

               (xviii) any contract or arrangement with any federal, state or
local government agency;

               (xix) any support contract with customers relating exclusively to
the Division Business; or

               (xx) any other agreement (or group of related agreements) the
performance of which involves consideration in excess of $10,000.

The Seller has delivered to the Purchaser a correct and complete copy of each
written agreement listed in the Disclosure Schedule (as amended to date) and a
written summary setting forth the terms and conditions of each oral agreement
referred to in the Disclosure Schedule. Except as disclosed in the Disclosure
Schedule, with respect to each such agreement: (i) the agreement is legal,
valid, binding, enforceable, and in full force and effect; (ii) subject to the
Purchaser obtaining the necessary consents disclosed in the Disclosure Schedule,
the agreement will continue to be legal, valid, binding, enforceable, and in
full force and effect on identical terms following the consummation of the
transactions contemplated hereby; (iii) no party is in breach or default, and no
<PAGE>
event has occurred which with notice or lapse of time would constitute a breach
or default, or permit termination, modification, or acceleration, under the
agreement; and (iv) no party has repudiated any provision of the agreement.

          (m) Seller is not a party to, or bound by, any unexpired, undischarged
or unsatisfied written contract, agreement, indenture, mortgage, debenture, note
or other instrument related to the Division Business under the terms of which
performance by Seller according to the terms of this Agreement will be a default
or an event of acceleration, or grounds for termination, or whereby timely
performance by Seller according to the terms of this Agreement may be
prohibited, prevented or delayed.

          (n) Seller possesses all licenses, permits, registration and
governmental approvals (the "Permits") (other than Environmental Permits) which
are required in order for the Seller to conduct the Division Business as
presently conducted. Neither the Seller nor any of its employees or independent
contractors is currently a party to any material transaction with a physician or
any relative of a physician by blood or marriage, or any affiliate or associate
of any physician, including, without limitation, any contract, agreement or
other arrangement providing for the furnishing of services to or by, providing
for rental of real or personal property to or from, or otherwise requiring
payments to or from (i) any such person, or (ii) any corporation, partnership,
trust or other entity in which any such person has an interest or of which such
person is an officer, director, trustee, or partner, or (iii) any officer,
director or employee of such a corporation, partnership, trust or other entity.

          EMPLOYEES

          (o) With respect to employees of Seller employed in the conduct of the
Division Business:

               (i) Seller maintains, administers, contributes to or has any
liability with respect to only those employee pension benefit plans (which in
respect of OrthoLogic shall be as defined in section 3(2) of the Employee
Retirement Income Security Act of 1974, as amended ("ERISA"), whether or not
excluded from coverage under specific Titles or Subtitles of ERISA) for the
benefit of employees of the Division Business which are described in the
Disclosure Schedule (the "Pension Plans");

               (ii) Seller maintains, administers, contributes to or has any
liability with respect to only those employee welfare benefit plans (which in
respect of OrthoLogic shall be as defined in Section 3(1) of ERISA, whether or
not excluded from coverage under specific Titles or Subtitles of ERISA) for the
benefit of employees of the Division Business which are described in the
Disclosure Schedule (the "Welfare Plans");

               (iii) Seller maintains, administers, contributes to or has any
liability with respect to only those employee benefit plans, programs, insurance
contracts, option plans, cafeteria plans, vacation pay, sick pay, holidays and
other employee arrangements that are not described in Section 3(3) of ERISA in
respect of OrthoLogic for the benefit of employees of the Division Business
which are described in the Disclosure Schedule (the "Non-ERISA Plans");
<PAGE>
               (iv) neither Seller nor any affiliate of Seller as determined
under Section 414(b), (c) , (m) or (o) of the Code ("ERISA Affiliate") has
incurred any liability to the Pension Benefit Guaranty Corporation ("PBGC") as a
result of the voluntary or involuntary termination of any pension plan subject
to Title IV of ERISA; there is currently no active filing by Seller or any ERISA
Affiliate with the PBGC (and no proceeding has been commenced by the PBGC) to
terminate any pension plan subject to Title IV of ERISA maintained or funded, in
whole or in part, by Seller or any ERISA Affiliate; and neither Seller nor any
ERISA Affiliate has made a complete or partial withdrawal from a multiemployer
plan, as such term is defined in Section 3(37) of ERISA, resulting in withdrawal
liability, as such term is defined in Section 4201 of ERISA (without regard to
subsequent reduction or waiver of such liability under either Section 4207 or
4208 of ERISA);

               (v) each Pension Plan which Seller maintains or contributes to
for the benefit of employees of the Division Business or OrthoLogic which is
intended to be qualified under section 401(a) of the Internal Revenue Code is,
to the best knowledge of Seller, so qualified; each such Pension Plan has
received a favorable determination letter from the Internal Revenue Service that
it is so qualified; and, to the best knowledge of the Seller, nothing has
occurred since receipt of such letter that is reasonably likely to result in
disqualification of any such Pension Plan;

               (vi) the OrthoCanada Pension Plans and Welfare Plans are duly
registered where required by, and are, in all respects, in good standing under
all applicable laws. All required employer and employee contributions and
premiums under the OrthoCanada Pension Plans and Welfare Plans have been made in
accordance with applicable laws, and there are no actions, claims or proceedings
pending relating to such plans.

               (vii) with respect to each Seller Pension Plan, Welfare Plan and
Non-ERISA Plan, Seller has provided to Purchaser accurate, current and complete
copies of each of the following: (a) where the plan has been reduced to writing,
the plan document together with all amendments; (b) where the plan has not been
reduced to writing, a written summary of all material plan terms; (c) any
summary plan descriptions, employee handbooks or similar employee
communications; (d) in the case of any qualified Pension Plan, the most recent
IRS determination letter; and (e) in the case of any defined benefit Pension
Plan, the three most recent annual returns/reports (Form 5500 series).

               (viii) no circumstance exists and no event (including any action
or the failure to do any act) has occurred with respect to any Pension Plan
maintained or formerly maintained by Seller or any related entity, or to which
Seller or any related entity is or has been required to contribute, that could
subject Purchaser to liability, or the assets of the Division Business to any
lien, under ERISA or any other law, nor will the transactions contemplated by
this Agreement give rise to any such liability or lien.

               (ix) no provision of any Seller Pension Plan would result in any
limitation on the ability of Seller or Purchaser to terminate participation in
the plan with respect to employees of the Division Business and to distribute
immediately their benefits under the Seller Pension Plan to them.
<PAGE>
               (x) the transactions contemplated by this Agreement shall not
alone or upon the occurrence of any additional or subsequent event, result in
any payment of severance or otherwise, or acceleration, vesting or increase in
benefits under any Pension Plan for the benefit of any current or former
director, officer or employee of the Seller in connection with the Division
Business.

               (xi) the transactions contemplated by this Agreement shall not
alone or upon the occurrence of any additional or subsequent event, other than a
qualifying event that occurs after the Closing, result in any obligation of the
Purchaser to provide COBRA continuation health coverage to any employee of the
Seller in the Division Business or related qualified beneficiary.

               (xii) there is no request for union representation or
certification pending or threatened against the Division Business;

               (xiii) there are no pending or threatened unfair labor practice
charges or complaints or employee grievance charges or complaints with respect
to the Division Business;

               (xiv) the Disclosure Schedule contains a list of all employees of
Seller employed in the conduct of the Division Business as of the date of this
Agreement ("Key Employees"), whose annual salaries exceed $100,000 and said list
correctly reflects their base salaries, bonuses, dates of employment and
positions;

               (xv) Seller has no reason to believe that any executive, key
employee, or group of employees relating to the Division Business has any plans
to terminate employment with the Seller. The Seller has not experienced any
labor disputes or work stoppage due to labor disagreements with regard to the
business of the Division Business. The Seller is not nor has it ever been a
party to any collective bargaining agreements and the Seller has not been the
subject of any organizational activity by any labor union, employee association,
or similar entity;

               (xvi) Seller has been and is in compliance in all respects with
all applicable laws respecting labor, employment and human resources practices,
terms and conditions of employment, wages and hours, including without
limitation any such laws respecting employment discrimination, workers'
compensation, human rights, employment standards, labor relations, pay equity,
occupational health and safety requirements; income and payroll taxes, employer
health taxes, Canada Pension and Employment Insurance;

               (xvii) Seller has not violated any applicable federal, state or
provincial law or regulation relating to labor, employment and human resources
practices and there are no actual or pending complaints or grievances, hearings,
actions, proceedings and appeals, or obligations to reinstate any former
employee of the Division Business which would have a Material Adverse Effect on
the Division Business; and

               (xviii) none of the employees of the Division Business is
represented by any labor union, employee association or similar entity, hold
bargaining, related employer or successor rights, and no collective bargaining
agreement is binding and in force against Seller with respect to the Division
Business or currently being negotiated by Seller with respect to the Division
Business.
<PAGE>
          LITIGATION, CLAIMS AND COMPLIANCE WITH LAWS

          (p) Except as disclosed in the Disclosure Schedule, there are no
judicial or administrative actions, claims, suits, proceedings or investigations
pending or threatened that would be reasonably likely to result in a Material
Adverse Effect, or that question the validity of this Agreement or of any action
taken or to be taken pursuant to or in connection with the provisions of this
Agreement nor is there any basis for any such action, claim, suit, proceeding or
investigation. There are no judgments, orders, decrees, citations, fines or
penalties heretofore assessed against the Seller affecting the Division
Business, the Purchased Assets or Assumed Liabilities under any federal, state,
provincial or local law, and there are no ongoing discussions, negotiations, or
efforts to resolve any audit, assessment, investigation, prosecution, breach of
any agreement or stipulation or other matter with any governmental agency,
agent, authority, carrier, intermediary or third party payor involving the
Seller or the Division Business.

          (q) Each product manufactured, sold, leased, or delivered by the
Division Business has been in conformity in all material respects with all
applicable federal, state, provincial, local or foreign laws and regulations,
contractual commitments and all express and implied warranties, and the Seller
has no liability (and there is no basis for any present or future action, suit,
proceeding, hearing, investigation, charge, complaint, claim, or demand giving
rise to any liability) for replacement or repair thereof or other damages in
connection therewith. Except as disclosed in the Disclosure Schedule, no product
manufactured, sold, leased, or delivered by the Seller in the operation of the
Division Business is subject to any guaranty, warranty, or other indemnity
beyond the applicable standard terms and conditions of sale or lease. The
Disclosure Schedule includes copies of the standard terms and conditions of sale
or lease for the Division Business (containing applicable guaranty, warranty,
and indemnity provisions). Seller has no liability (and there is no basis for
any present or future action, suit, proceeding, hearing, investigation, charge,
complaint, claim, or demand against any of them giving rise to any liability)
arising out of any injury to individuals or property as a result of the
ownership, possession, or use of any product manufactured, sold, leased, or
delivered by the Seller in the operation of the Division Business and there has
been no inquiry or investigation made in respect thereof by any person including
any governmental or administrative agency.

          (r) The Seller has no liability (and there is no basis for any present
or future action, suit, proceeding, hearing, investigation, charge, complaint,
claim, or demand against it giving rise to any such liability) arising or
attributable to the Division Business, except for (i) liabilities set-forth on
<PAGE>
the face of the Pro Forma Balance Sheet (rather than in any notes thereto), (ii)
liabilities which have arisen after the date of the Pro Forma Balance Sheet in
the Ordinary Course of Business (none of which liabilities referred to under
subsection (ii) of results from, arises out of, relates to, is in the nature of,
or was caused by any breach of contract, breach of warranty, tort, infringement,
or violation of law), and (iii) liabilities of the Division Business set forth
on the Disclosure Schedule.

          (s) The Seller is in compliance with all applicable laws the violation
of which, either singularly or in the aggregate, could have a Material Adverse
Effect on the Division Business and no action, suit, proceeding, hearing,
investigation, charge, complaint, claim, demand, or notice has been filed or
commenced against any of them alleging any failure so to comply. Neither the
ownership nor use of properties of the Division Business nor the conduct of the
business of the Division Business (i) conflicts with the rights of any other
person or entity or, to Seller's knowledge, such other person's or entity's
charter or bylaws or (ii) violates, or with the giving of notice or the passage
of time or both will violate, conflict with or result in a default, right to
accelerate or loss of rights under, any terms or provisions of any lien, lease,
license, agreement, understanding, law, ordinance, rule or regulation, or any
order, judgment or decree to which the Division Business is a party or by which
the Division Business may be bound or affected. No proposed laws, rules,
regulations, ordinances, orders, judgments, decrees, governmental takings,
condemnations or other proceedings exist which would be applicable to the
business, operations or properties of the Division Business and which might
adversely affect such properties, assets, liabilities, operations or prospects.

          ENVIRONMENTAL MATTERS

          (t) Except as disclosed in the Disclosure Schedule:

               (i) the Seller in connection with the Division Business has
complied and is in compliance with all applicable Environmental Laws and Safety
Laws the violation of which could have a Material Adverse Effect;

               (ii) the Seller in connection with the Division Business has
obtained, and is and has been in compliance with the conditions of, all
Environmental Permits required for the continued conduct of the Division
Business in the manner now conducted and presently proposed to be conducted;

               (iii) the Seller in connection with the Division Business has
filed all required applications, notices and other documents necessary to effect
the timely renewal or issuance of all Environmental Permits for the continued
conduct of the Division Business in the manner now conducted and presently
proposed to be conducted;

               (iv) there are no past or present events, conditions or
circumstances, including, without limitation, to the knowledge of Seller (and
Seller's employees responsible for environmental matters), pending changes in
any Environmental Law or Permit or Safety Laws, that are likely to interfere
with or otherwise affect the Division Business in the manner now conducted or
which would interfere with compliance with any Environmental Law or Permit or
Safety Law;

               (v) there are no circumstances or conditions present at or
arising out of the present or former assets, properties, leaseholds, businesses
or operations of the Seller in connection with the Division Business in respect
of off-site storage, transportation or disposal of, or any off-site Release of,
a Chemical Substance which reasonably may be expected to give rise to any
Environmental Liabilities and Costs;

               (vi) there are no circumstances or conditions present at or
arising out of the present or former assets, properties, leaseholds, businesses
or operations of the Seller in connection with the Division Business, including
but not limited to any on-site storage, use, disposal or Release of a Chemical
Substance, which reasonably may be expected to give rise to any Environmental
Liabilities and Costs or Safety Liabilities and Costs;
<PAGE>
               (vii) none of the Seller in connection with the Division Business
or the present or past assets, properties, businesses, leaseholds or operations
of the Seller in connection with the Division Business has received or is
subject to, or within the past three years has been subject to, any outstanding
order, decree, judgment, complaint, agreement, claim, citation, or notice or is
subject to any ongoing judicial or administrative proceeding alleging or
otherwise indicating that the Seller or the past and present assets of the
Division Business are or may be: (a) in violation of any Environmental Law; (b)
in violation of any Safety Laws; (c) responsible for the on-site or off-site
storage or Release of any Chemical Substance; or, (d) liable for any
Environmental Liabilities and Costs or Safety Liabilities and Costs;

               (viii) the Seller has no reason to believe that the Division
Business will become subject to a matter identified in subsection (vii); and, no
investigation or review with respect to such matters is pending or, to the
knowledge of the Seller (and Seller's employees responsible for environmental
matters), is threatened, nor has any authority or other third-party indicated an
intention to conduct such investigation or review;

               (ix) neither the Division Business nor any of the Purchased
Assets is subject to, or as a result of the transactions contemplated by this
Agreement will be subject to, the requirements of any Environmental Laws or
other laws which require notice, disclosure, cleanup or approval prior to
transfer of such Purchased Assets or the Division Business or which will impose
liens on such Purchased Assets or otherwise interfere with or affect the
Division Business ("Environmental Transfer Laws") or if subject to such
requirements, the Seller has complied therewith;

               (x) the Disclosure Schedule lists all real property presently or
previously leased, owned or operated by the Seller in connection with the
Division Business and identifies all such property (and the area within that
property) that has been used by the Division Business or by any other person or
entity (including a prior owner or operator) for the storage or disposal of
Chemical Substances;

               (xi) the Disclosure Schedule lists all off-site locations,
including, without limitation, commercial waste disposal facilities or municipal
landfills, to which or at which Chemical Substances originating from the
Division Business or the Purchased Assets have been sent (or otherwise have come
to be located) in amounts that would require a waste manifest under the Resource
Conservation and Recovery Act of 1976 as now in effect for treatment, storage,
disposal, reuse or recycling;

               (xii) the Disclosure Schedule sets forth a list of all
underground storage tanks owned or operated at any time by the Seller in
connection with the Division Business and except as disclosed in the Disclosure
Schedule, no such tank is leaking or has leaked at any time in the past, and
there is no pollution or contamination of the Environment caused by or
contributed to or threatened by a Release of a Chemical Substance from any such
tank; and

               (xiii) the Disclosure Schedule lists all environmental audits,
inspections, assessments, investigations or similar reports in the Seller's
possession or of which the Seller is aware relating to the Purchased Assets or
the Division Business or the compliance of the same with applicable
Environmental Laws and Safety Laws.
<PAGE>
               For purposes of this ss.(t) only, all references to the "Seller"
are intended to include any and all other entities to which the Seller may be
considered a successor under applicable Environmental Laws. The representations
and warranties in this section are the only representations and warranties with
respect to Environmental Laws or Environmental Liabilities and Costs, or Safety
Laws or Safety Liabilities and Costs notwithstanding any other language in this
Agreement of general applicability.

               For the purposes of this Agreement:

               "Chemical Substance" means any chemical substance, including but
not limited to any (i) pollutant, contaminant, irritant, chemical, raw material,
intermediate, product, by-product, slag, construction debris; (ii) industrial,
solid, liquid or gaseous toxic or hazardous substance, material or waste, (iii)
petroleum or any fraction thereof; (iv) asbestos or asbestos-containing
material; (v) polychlorinated biphenyl; (vi) urea formaldehyde foam insulation;
(vii) chlorofluoracarbons; and (viii) other substance, material or waste, which
is identified prohibited, controlled or regulated under any Environmental Law or
Safety Law, as now and hereinafter in effect, or other comparable laws.

               "Environment" means soil, land surface or subsurface strata, real
property, surface waters (including navigable waters, ocean waters, streams,
ponds, drainage basins and wetlands), groundwater, water body sediments,
drinking water supply, stream sediments, ambient air (including indoor air),
plant and animal life and any other environmental medium or natural resource.

               "Environmental Laws" mean the Comprehensive Environmental
Response, Compensation and Liability Act, the Resource Conservation and Recovery
Act, the Clean Air Act, and the Clean Water Act, each, as amended or hereinafter
in effect and any other federal, state, provincial, local or foreign law,
regulation ordinance rule guideline order, directive or other legal requirement,
as now or hereinafter in effect, relating to: (i) the Release, containment,
removal, remediation, response, cleanup or abatement of any sort of any Chemical
Substance; (ii) the manufacture, generation, formulation, processing, labeling,
distribution, introduction into commerce, use, treatment, handling, storage,
recycling, disposal or transportation of any Chemical Substance; (iii)exposure
of persons, including employees, to any Chemical Substance; (iv) the physical
structure, use or condition of a building, facility, fixture or other structure,
including, without limitation, those relating to the management, use, storage,
disposal, cleanup or removal of asbestos, asbestos-containing materials,
polychlorinated biphenyls or any other Chemical Substance; (v) the pollution,
protection or clean up of the Environment; or (vi)noise.

               "Environmental Liabilities and Costs" means all losses incurred:
(i) to comply with any Environmental Law; (ii) as a result of a Release of any
Chemical Substance; or, (iii) as a result of any environmental conditions
present at, created by or arising out of the past or present operations of
Seller through the Closing Date or of any prior owner or operator of a facility
or site at which Seller now owns or operates or has previously owned or
operated.
<PAGE>
               "Environmental Permit" means any permit or authorization from any
governmental authority required under, issued pursuant to, or authorized by any
Environmental Law.

               "Release" means any actual, threatened or alleged spilling,
leaking, pumping, pouring, emitting, dispersing, emptying, discharging,
injecting, escaping, leaching, dumping, or disposing of any Chemical Substance
into the Environment that may cause an Environmental Liability and Cost
(including the disposal or abandonment of barrels, containers, tanks or other
receptacles containing or previously containing any Chemical Substance).

               "Safety Laws" means any federal, state, provincial, local and
foreign law, regulation or legal requirement relating to health or safety,
including the Occupational Safety and Health Act, as amended, as now or
hereinafter in effect relating to (i) exposure of employees to any Chemical
Substance or (ii) the physical structure, use or condition of a building,
facility, fixture or other structure, including, without limitation, those
relating to equipment or manufacturing processes, or the management, use,
storage, disposal, cleanup or removal of any Chemical Substance.

               "Safety Liabilities and Costs" means all Losses incurred to
comply with any Safety Law or as a result of any health or safety conditions
present at, created by or arising out of the past or present operations of the
Seller through the Closing Date.

               LEASED PREMISES

          (u) The Seller does not own any real property that is used in
connection with the business or operations of the Division Business. The
Disclosure Schedule lists all real property leased or subleased in connection
with the business or operations of the Division Business. The Seller has
delivered to the Purchaser correct and complete copies of the leases and
subleases listed in the Disclosure Schedule (as amended to date) which such
leases and subleases have not been amended or modified since the date thereof.
With respect to each lease and sublease listed in the Disclosure Schedule:

               (i) the lease or sublease is legal, valid, binding, enforceable,
and in full force and effect;

               (ii) the lease or sublease will continue to be legal, valid,
binding, enforceable, and in full force and effect on identical terms following
the consummation of the transactions contemplated hereby;

               (iii) no party to the lease or sublease is in breach or default,
and no event has occurred which, with notice or lapse of time, would constitute
a breach or default or permit termination, modification, or acceleration
thereunder;

               (iv) no party to the lease or sublease has repudiated any
provision thereof;

               (v) there are no disputes, oral or written agreements, or
forbearance programs in effect as to the lease or sublease;
<PAGE>
               (vi) with respect to each sublease, the representations and
warranties set forth in subsections (i) through (v) above are true and correct
with respect to the underlying lease;

               (vii) the Seller has not assigned, transferred, conveyed,
mortgaged, deeded in trust, or encumbered any interest in the leasehold or
subleasehold;

               (viii) with respect to each real property which is leased or
subleased there is either no mortgage on the fee interest in such property which
predates such lease or a non-disturbance agreement protecting the tenant's
leasehold interest has been obtained and a current and complete copy provided to
the Purchaser;

               (ix) there are no pending or threatened condemnation proceedings,
lawsuits, or administrative actions relating to the premises leased by the
Seller in the operation of the Division Business or other matters which would
adversely affect the use or occupancy thereof;

               (x) there are no leases, subleases, licenses, concessions, or
other agreements, written or oral, granting to any party or parties the right of
use or occupancy of the premises leased by the Seller in the operation of the
Division Business or any portion thereof;

               (xi) all facilities leased or subleased thereunder have received
all approvals of governmental authorities (including licenses and permits)
required in connection with the operation thereof and have been operated and
maintained in accordance with applicable laws, rules, and regulations; and

               (xii) all facilities leased or subleased thereunder are supplied
with utilities and other services necessary for the operation of said
facilities.

               The Seller owns or leases all buildings, real property,
improvements, machinery, equipment, and other tangible assets necessary for the
conduct of the Division Business as presently conducted or as proposed to be
conducted by Seller. Each such tangible asset is free from defects (patent and
latent), has been maintained in accordance with normal industry practice, is in
satisfactory operating condition and repair (subject to normal wear and tear),
and is suitable, adequate and sufficient for the purposes for which it presently
is used and presently is proposed to be used.

          INTELLECTUAL PROPERTY

          (v) The Seller owns or has the right to use pursuant to license,
sublicense, agreement, or permission all Intellectual Property. Subject to
obtaining all necessary consents as disclosed in the Disclosure Schedule, each
item of Intellectual Property owned or used by the Seller exclusively in
connection with the Division Business immediately prior to the Closing hereunder
will be owned or available for use by the Purchaser on identical terms and
conditions immediately subsequent to the Closing hereunder and is listed on the
Disclosure Schedule. Except as disclosed in the Disclosure Schedule, the Seller
has taken all necessary and desirable action to maintain and protect each item
of Intellectual Property that it owns or uses, including, without limitation,
payment of all maintenance and annuity fees due.
<PAGE>
          (w) Except as disclosed in the Disclosure Schedule, the Seller has not
interfered with, infringed upon, misappropriated, or otherwise come into
conflict with any Intellectual Property rights of third parties, and there has
never been any charge, complaint, claim, demand, or notice alleging any such
interference, infringement, misappropriation, or violation (including any claim
that the Seller must license or refrain from using any Intellectual Property
rights of any third party). No third party has interfered with, infringed upon,
misappropriated, or otherwise come into conflict with any Intellectual Property
rights of the Seller.

          (x) All of the Seller's employees that have participated in the
development of the Products have entered into employee agreements with the
Seller assigning all right, title and interest in the Intellectual Property
therein to the Seller. Pursuant to such employee agreements or applicable law,
the Seller owns all of the right, title and interest of their employees to any
Intellectual Property in the Products.

          (y) The Disclosure Schedule identifies each patent or registration
which has been issued to the Seller with respect to its Intellectual Property,
identifies each pending patent application or application for registration which
has been made with respect to the Seller's Intellectual Property, and identifies
each license, agreement, or other permission which the Seller has granted to any
third party with respect to any of the Intellectual Property. The Seller has
delivered to the Purchaser correct and complete copies of all such patents,
registrations, applications, licenses, agreements, and permissions (as amended
to date) and has made available to the Purchaser correct and complete copies of
all other written documentation evidencing ownership and prosecution (if
applicable) of each such item. The Disclosure Schedule also identifies each
trade name or unregistered trademark or servicemark used by the Seller in
connection with the Division Business. With respect to each item of Intellectual
Property required to be identified in the Disclosure Schedule:

               (i) except as disclosed in the Disclosure Schedule, the Seller
possesses all right, title, and interest in and to the item, free and clear of
any lien, license, or other restriction;

               (ii) the item is not subject to any outstanding injunction,
judgment, order, decree, ruling, or charge;

               (iii) no action, suit, proceeding, hearing, investigation,
charge, complaint, claim, or demand is pending or threatened which challenges
the legality, validity, enforceability, use, or ownership of the item; and

               (iv) the Seller has never agreed to indemnify any person or
entity for or against any interference, infringement, misappropriation, or other
conflict with respect to the item.

          (z) The Disclosure Schedule identifies each item of Intellectual
Property that any third party owns and that the Seller uses exclusively in
connection with the Division Business pursuant to license, sublicense,
agreement, or permission. The Seller has delivered to the Purchaser correct and
complete copies of all such licenses, sublicenses, agreements, and permissions
<PAGE>
(as amended to date). With respect to each item of Intellectual Property
required to be identified in the Disclosure Schedule:

               (i) the license, sublicense, agreement, or permission covering
the item is legal, valid, binding, enforceable, and in full force and effect;

               (ii) subject to obtaining necessary consents as disclosed in the
Disclosure Schedule, the license, sublicense, agreement, or permission will
continue to be legal, valid, binding, enforceable, and in full force and effect
on identical terms following the consummation of the transactions contemplated
hereby;

               (iii) no party to the license, sublicense, agreement, or
permission is in breach or default, and no event has occurred which with notice
or lapse of time would constitute a breach or default or permit termination,
modification, or acceleration thereunder;

               (iv) no party to the license, sublicense, agreement, or
permission has repudiated any provision thereof;

               (v) with respect to each sublicense, the representations and
warranties set forth in subsections (i) through (v) above are true and correct
with respect to the underlying license;

               (vi) the underlying item of Intellectual Property is not subject
to any outstanding injunction, judgment, order, decree, ruling, or charge;

               (vii) no action, suit, proceeding, hearing, investigation,
charge, complaint, claim, or demand is pending or is threatened, which
challenges the legality, validity, or enforceability of the underlying item of
Intellectual Property; and

               (viii) the Division Business has not granted any sublicense or
similar right with respect to the license, sublicense, agreement, or permission.

          (aa) The Division Business will not interfere with, infringe upon,
misappropriate, or otherwise come into conflict with, any Intellectual Property
rights of third parties as a result of the continued operation of its businesses
as presently conducted and proposed to be conducted by Seller.

          (bb) For the purpose of this Agreement:

          "Intellectual Property" means the entire right, title and interest in
and to all proprietary rights of every kind and nature, including Patents,
copyrights, Trademarks, mask works, trade secrets, software and proprietary
information; all applications for any of the foregoing, and any license or
agreements granting rights related to the foregoing (i) subsisting in, covering,
reading on, directly applicable to or existing in the Products or the
Technology; (ii) that are owned, licensed or controlled in whole or in part by
the Division Business; or (iii) that are used in or necessary to the
development, manufacture, sales, marketing or testing of the Products.
<PAGE>
          "Patent" means any: (i) United States or Canadian or foreign patent,
patent application, patent disclosure or other patent right; (ii) any division,
continuation, continuation-in-part or similar extension of an application that
is a Patent; and (iii) any patent or other patent right that issues or is based
upon an application that is a Patent.

          "Products" means all current products and services of the Division
Business including those identified in the Disclosure Schedule, any subsequent
or new versions of existing or prior products currently being developed, any
products currently being developed by the Division Business which are designed
to supersede, replace or function as a component of such products, and any
upgrades, enhancements, improvements and modifications to the foregoing.

          "Technology" means all inventions, copyrightable works, discoveries,
innovations, know-how, information (including ideas, research and development,
know-how, formulas, compositions, processes and techniques, technical data,
designs, drawings, specifications, customer and supplier lists, pricing and cost
information, business and marketing plans and proposals, documentation, and
manuals), computer software, computer hardware, integrated circuits and
integrated circuit masks, electronic, electrical and mechanical equipment and
all other forms of technology, including improvements, modifications,
derivatives or changes, whether tangible or intangible, embodied in any form,
whether or not protectible or protected by patent, copyright, mask work right,
trade secret law or otherwise that (i) were conceived, developed, or reduced to
practice by or for the Division Business, or (ii) are incorporated, embodied or
used in or are used to develop, manufacture, test, market, distribute or
maintain and support the Products.

          "Trademarks" means any trademarks, service marks, trade dress, and
logos together with all translations, adaptations, derivations, and combinations
thereof and including all goodwill associated therewith.

          SOLVENCY/MEDICARE/MEDICAID

          (cc) No injunction, bankruptcy petition, writ, restraining order or
other order of any material nature adverse to the Seller or the conduct of its
business or which is inconsistent with the due consummation of the transactions
contemplated by this Agreement has been issued by or filed with a Governmental
Authority. The Seller has complied in all material respects with all applicable
laws, rules, regulations, and orders with respect to it, its business and
properties and all Purchased Receivables and related Payor Contracts (including
without limitation, all applicable environmental, health and safety
requirements) and all restrictions contained in any indenture, loan or credit
agreement, mortgage, security agreement, bond, note, or other agreement or
instrument binding on or affecting the Seller or its property, and has and
maintains all permits, licenses, authorizations, registrations, approvals and
consents of Governmental Authorities necessary for the activities and business
of the Seller and each of its Subsidiaries as currently conducted and as
proposed to be conducted by Seller, the ownership, use, operation and
maintenance by each of them of its properties, facilities and assets and the
performance by the Seller of this Agreement (hereinafter referred to
collectively as "Governmental Consents");
<PAGE>
          (dd) Without limiting the generality of the prior representation: (i)
each of the Blue Cross/Blue Shield Contracts of the Seller and each of its
Subsidiaries is in full force and effect and has not been amended or otherwise
modified, rescinded or revoked or assigned since December 31, 2000, (ii) the
Seller and each Subsidiary is in compliance with the requirements of CHAMPUS,
CHAMPVA and related programs, and the Blue Cross/Blue Shield Contracts, and
(iii) no condition exists or event has occurred which, in itself or with the
giving of notice or lapse of time or both, would result in the suspension,
revocation, impairment, forfeiture, non-renewal of any Governmental Consent
applicable to the Seller or any other health care facility owned or operated by
the Seller or any of its Subsidiaries, or such facility's participation in any
CHAMPUS, CHAMPVA or other similar program, or of any Blue Cross/Blue Shield
Contracts and there is no claim that such Governmental Consent, participation or
contract is not in full force and effect;

          (ee) The primary business of the Seller is the provision of health
care services and/or equipment. The Payors' related provider numbers listed on
the Disclosure Schedule have been issued to the Seller and such list is a true
and complete list of all provider numbers assigned by Payors to the Seller or
its Subsidiaries;

          (ff) The Seller is solvent and will not become insolvent after giving
effect to the transactions contemplated by this Agreement; the Seller has not
incurred Debts beyond its ability to pay; the Seller, after giving effect to the
transactions contemplated by this Agreement, will have an adequate amount of
capital to conduct its business in the foreseeable future; and the sales of
Purchased Receivables hereunder are made in good faith and without intent to
hinder, delay or defraud present and future creditors of the Seller;

          (gg) The legal name of the Seller is as set forth at the beginning of
this Agreement and the Seller has not changed its name in the last six years
and, during such period, the Seller did not use, nor does the Seller now use,
any tradenames, fictitious names, assumed names or "doing business as" names
other than those tradenames, fictitious names, assumed names or "doing business
as" names set forth on the Disclosure Schedule attached hereto;

          (hh) During the past four months, there have not been any other
locations at which the Seller has been located (as that term is used in the UCC)
or where Records are currently being kept or have been kept except as set forth
on the Disclosure Schedule;

          (ii) The principal place of business, chief executive office location
(as that term is used in the UCC), telephone number and telefax number of the
Seller are as set forth on the Disclosure Schedule;

          (jj) No Payor of an Eligible Purchased Receivable being sold has any
claim of a material nature against or affecting the Seller or the property of
the Seller;

          (kk) The Seller has not done and shall not do anything to impede or
interfere with the collection by the Purchaser of the Purchased Receivables and
shall not amend, waive or otherwise permit or agree to any deviation from the
terms or conditions of any Purchased Receivable or any related Payor Contract;
<PAGE>
          (ll) The Seller has made and will continue to make all payments to
Payors necessary to prevent any Payor from offsetting any earlier overpayment to
the Seller against any amounts such Payor owes on a Purchased Receivable;

          PURCHASED RECEIVABLES

          (mm) With respect to each Purchased Receivable sold pursuant to this
Agreement (including, without limitation, claims which may be satisfied by
set-off of any amounts due under any Purchased Receivable), the Seller
represents and warrants, as follows:

               (i) Such Purchased Receivable is the primary liability of an
Eligible Payor and is or will be recognized by the Eligible Payor as its primary
liability;

               (ii) The Seller has or will submit all documentation to Purchaser
regarding Purchased Receivables in its possession as of the time of Closing and
any additional documentation that Seller receives following the Closing
regarding such Purchased Receivables;

               (iii) Neither the Purchased Receivable nor the related Payor
Contract has been satisfied, subordinated or rescinded, or except as disclosed
on the Disclosure Schedule;

               (iv) Such Purchased Receivable is an account receivable created
through the provision of medically necessary services or merchandise supplied by
the Seller in the ordinary course of its business and the sales prices of such
services or merchandise were usual, customary and reasonable in the Seller's
community for such services;

               (v) Such Purchased Receivable is an "account" within the meaning
of the UCC and is not evidenced by an "instrument" within the meaning of the
UCC;

               (vi) To the extent a Purchased Receivable relates to a Payor
Contract, the related Payor Contract is, and was at the time of the services
giving rise to the Purchased Receivable, in full force and effect and
constitutes the legal, valid and binding obligation of the Payor enforceable
against such Payor in accordance with its terms, such Purchased Receivable was
created in accordance with the requirements of the Payor Contract and applicable
law, including without limitation, to the extent the Purchased Receivable is
subject to limitations imposed by workers' compensation law or a related Payor
Contract and is entitled to be paid pursuant to the terms of the related Payor
Contract, and a copy of any related Payor Contract to which the Seller is a
party has been delivered to the Purchaser;

               (vii) Such Purchased Receivable is owned by the Seller free and
clear of any Adverse Claim, and the Seller has the right to sell, assign and
transfer the same and interests therein as contemplated under this Agreement
and, upon such sale, the Purchaser has acquired a valid ownership interest in
such Purchased Receivable, free and clear of any Adverse Claim;

               (viii) No consent from the Payor or any other Person shall be
required to effect the sale of any Purchased Receivables;

               (ix) There are no procedures or investigations pending or to
Seller's knowledge threatened before any Governmental Authority (a) asserting
the invalidity of such Purchased Receivable or such Payor Contract, (b)
<PAGE>
asserting the bankruptcy or insolvency of the related Payor, (c) seeking the
payment of such Purchased Receivable or payment and performance of such Payor
Contract or (d) seeking any determination or ruling that might materially and
adversely affect the validity or enforceability of such Purchased Receivable or
such Payor Contract;

               (x) Neither such Purchased Receivable nor the related Payor
Contract contravenes in any material respect any laws, rules or regulations
applicable thereto (including, without limitation, laws, rules and regulations
relating to usury, consumer protection, truth in lending, fair credit billing,
fair credit reporting, equal credit opportunity, fair debt collection practices
and privacy) and no party to such related Payor Contract is in violation of any
such law, rule or regulation in any material respect;

               (xi) The Seller has no knowledge of any fact which should have
led it to expect at the time of sale of such Purchased Receivable to the
Purchaser that the Purchased Receivable would not be paid in full.

          GENERAL

          (nn) The Seller is not a guarantor or otherwise liable for any
liability or obligation of any person or entity for any matter which relates to
or affects or will affect the Division Business.

          (oo) Since the date of the Year End Financial Statements, there has
not been any change which has resulted in a Material Adverse Effect and no event
has occurred or circumstance exists that is reasonably likely to result in such
a Material Adverse Effect.

          (pp) All notes and accounts receivable of the Seller in respect of the
Division Business are reflected properly on its books and records in accordance
with GAAP, are valid receivables, arose from bona fide transactions in the
Ordinary Course of Business, subject to no setoffs or counterclaims except as
recorded as accounts payable, are current and collectible and will be collected
in accordance with their terms at their recorded amounts without having to or
threaten to resort to any collection efforts or legal proceedings outside the
Ordinary Course of Business, except as reflected as net of allowance for bad
debts on the face of the Pro Forma Balance Sheet (rather than in any notes
thereto or reserve therefore) as adjusted for the passage of time through the
closing date in accordance with GAAP and past practice and custom of the Seller.

          (qq) Except pursuant to this Agreement, there are no outstanding
powers of attorney executed on behalf of any of the Seller in respect of the
Division Business, its assets, liabilities or business.

          (rr) The Division Business has been covered during the past 5 years by
insurance in scope and amount customary and reasonable for the businesses in
which it has engaged during the aforementioned period. The Disclosure Schedule
describes any self-insurance arrangements affecting the Division Business.
<PAGE>
          (ss) Except as set forth in the Disclosure Schedule, the Seller and
its Affiliates do not own or otherwise have any rights to or interests in any
asset, tangible or intangible, which is used in the business of the Division
Business which is not being transferred as a Purchased Asset, other than the
Excluded Assets.

          (tt) Except as set forth in the Disclosure Schedule, the Seller has
not been and is not a party to any contract or arrangement with any federal,
state, provincial, or local government agency relating to the Division Business.

          (uu) The books and all corporate and financial records of the Division
Business are complete and correct in all material respects and have been
maintained in accordance with applicable sound business practices, laws and
other requirements.

          (vv) The Disclosure Schedule sets forth a true, correct and complete
list of the identities of any person or entity whose consent or approval is
required and the matter, agreement or contract to which such consent relates in
connection with the transfer, assignment or conveyance by the Seller of any of
the Purchased Assets.

          (ww) The representations and warranties contained in this ss.4.3
(including the Disclosure Schedule and any other schedules and exhibits required
to be delivered by Seller to Purchaser pursuant to this Agreement) and any
certificate furnished or to be furnished by Seller to Purchaser do not contain
any untrue statement of a material fact or omit to state any material fact
necessary in order to make the statements and information contained in this
ss.4.3 not misleading. There is no fact relating to the Division Business or the
Purchased Assets which may materially adversely affect the same which has not
been disclosed in writing in this Agreement to the Purchaser.

          (xx) The Purchased Assets comprise all of the assets, properties and
rights of every type and description, real, personal, tangible and intangible
used by the Division Business or necessary in the conduct of its business as it
is currently conducted or as currently proposed to be conducted by Seller and
the Purchased Assets conveyed to Purchaser on the Closing Date will represent
the totality of assets required to enable Purchaser to continue to conduct the
Division Business as it is presently being conducted.

          (yy) Neither Seller, nor any of its Affiliates, has any liability or
obligation to pay any person or entity for a broker's commission, finder's fee,
investment banker's fee or similar payment with respect to the transactions
contemplated hereby or introducing the parties to each other.

          (zz) The Purchased Assets are all or substantially all of the property
used in a commercial activity that forms all or a part of a business carried on
by OrthoCanada. OrthoCanada has not been and is not now a financial institution
for the purposes of the Excise Tax Act (Canada). OrthoCanada is a registrant for
the purposes of the Excise Tax Act (Canada), registration number
89072-5443-RM001.

          (aaa) The Seller, together with its affiliates (as defined in the
Competition Act (Canada)) have assets in Canada with an aggregate value of
approximately $4,900,000 and gross revenues from sales in, from or into Canada
<PAGE>
with an aggregate value of $3,000,000 as set out in the Year End Financial
Statements.

          (bbb) The gross assets of OrthoCanada's portion of the Division
Business as shown on such Year End Financial Statements is approximately
$5,300,000.

          (ccc) The Seller is not required to collect or remit any taxes under
the Retail Sales Tax Act (Ontario) in respect of the Division Business.

          (ddd) For the purposes of this Section 4.3, the following terms shall
have the indicated meanings:

          "Adverse Claim" shall mean any claim of ownership or any lien,
security interest or other charge or encumbrance, or other type of preferential
arrangement having the effect of a lien or security interest;

          "Blue Cross/Blue Shield Contracts" shall mean any and all agreements
currently in force between the Seller and any Blue Cross/Blue Shield plan;

          "CHAMPUS" shall mean the Civilian Health and Medical Program of the
Uniformed Service, a program of medical benefits covering retirees and
dependents of a member or a former member of a uniformed service, provided,
financed and supervised by the United States Department of Defense established
by 10 USC ss.ss. 1071 et seq.;

          "CHAMPVA" shall mean the Civilian Health and Medical Program of the
Veterans Administration, a program of medical benefits covering (i) the
dependents of veterans who have been rated by VA as having a total and permanent
disability, (ii) the survivors of veterans who died from VA-rated
service-connected conditions, or (iii) those who at the time of death, were
rated permanently and totally disabled from a VA-rated service-connected
condition;

          "Collections" means, with respect to any Purchased Receivable, all
cash collections and other cash proceeds of such Purchased Receivable;

          "Payor Contract" shall mean an agreement (or agreements), pursuant to,
or under which, a Payor shall be obligated to pay the Seller for services
rendered or merchandise sold to patients of the Seller from time to time;

          "Debts" shall mean of any Person (i) indebtedness of such Person for
borrowed money, (ii) obligations of such Person evidenced by bonds, debentures,
notes or other similar instruments, (iii) obligations of such Person to pay the
deferred purchase price of property or services, (iv) obligations of such Person
as lessee under leases which have been or should be, in accordance with
generally accepted accounting principles, recorded as capital leases, (v)
obligations secured by any lien or other charge upon property or assets owned by
such Person, even though such Person has not assumed or become liable for the
payment of such obligations, (f) obligations of such Person under direct or
indirect guaranties in respect of, and obligations (contingent or otherwise) to
purchase or otherwise acquire, or otherwise to assure a creditor against loss in
respect of, indebtedness or obligations of others of the kinds referred to in
clauses (i) through (v) above, and (vi) liabilities in respect of unfunded
vested benefits under plans covered by Title IV of the Employee Retirement
Income Security Act of 1974, as amended;
<PAGE>
          "Governmental Authority" shall mean the United States of America,
federal, any state, local or other political subdivision thereof and any entity
exercising executive, legislative, judicial, regulatory or administrative
functions thereof or pertaining thereto;

          "HHS" shall mean the Department of Health and Human Services, an
agency of the Federal Government of the United States;

          "HMO" shall mean a health maintenance organization;

          "Lockbox Account" shall mean the lockbox at Wells Fargo Bank set up
pursuant to the Lockbox Agreement (as defined below) by and among the Purchaser,
the Seller, NCFE (as defined below) and Wells Fargo Bank;

          "Medicaid" shall mean the medical assistance program established by
Title XIX of the Social Security Act (42 USCss.ss.1396 et seq.) and any statutes
succeeding thereto;

          "Medicare" shall mean the health insurance program for the aged and
disabled established by Title XVIII of the Social Security Act (42 USCss.ss.1395
et seq.) and any statutes succeeding thereto;

          "Payors" shall mean with respect to any Purchased Receivable, the
Person primarily obligated to make payments in respect thereto;

          "Person" means an individual, partnership, corporation (including a
business trust), joint stock company, trust, voluntary association, joint
venture, a government or any agency or political subdivision thereof, or any
other entity of whatever nature;

          "PPO" shall mean a preferred provider organization;

          "Records" shall mean all Payor Contracts and other documents, books,
records and other information (including, without limitation, computer programs,
tapes, disks, punch cards, data processing software and related property and
rights) prepared and maintained by the Seller with respect to the Purchased
Receivables and the related Payors as related to the Purchased Receivables;

          "UCC" means the Uniform Commercial Code as from time to time in effect
in the state of the location of the Seller's chief executive office; (or similar
personal property security legislation of various Canadian provinces).

     4.4 DEFINITION OF KNOWLEDGE. For the purposes of this Agreement, the terms
"knowledge of Seller" or "Seller's knowledge" or words of similar import shall
be deemed to include the actual knowledge as of the Closing Date of any or all
of Thomas R. Trotter, Terry D. Meier and Sherry Sturman, as well as such
knowledge as a prudent person in a similar position would have upon a reasonable
investigation or inquiry of relevant facts and circumstances.
<PAGE>
                                   ARTICLE 5

                          CONDUCT PRIOR TO THE CLOSING

     5.1 GENERAL. Seller and Purchaser shall have the rights and obligations
with respect to the period between the date hereof and the Closing Date which
are set forth in the remainder of this Article V.

     5.2 SELLER'S OBLIGATIONS. The following are Seller's obligations:

          (a) Seller shall give to Purchaser's officers, employees, attorneys,
consultants, accountants and lenders reasonable access during normal business
hours to all of the properties, books, contracts, documents, records and
personnel of Seller relating to the Division Business and shall furnish to
Purchaser such information as Purchaser may at any time and from time to time
reasonably request.

          (b) Seller shall use its best efforts and make every good faith
attempt (and Purchaser shall cooperate with Seller) to obtain the consents to
the assignment of those contracts, leases, or other instruments, or other
consents of third parties, which are enumerated in SCHEDULE 5.2(B) attached
hereto (the "Material Consents").

          (c) The Seller will not engage in any practice, take any action, or
enter into any transaction outside the Ordinary Course of Business in respect of
the Division Business. Without limiting the generality of the foregoing, the
Seller (i) will not, in respect of the Division Business, engage in any
practice, take any action, or enter into any transaction of the sort described
in ss. 4.3(k) above and (ii)in respect of the Division Business, will (A)
preserve for the benefit of Purchaser the goodwill of the Division Business'
customers, suppliers, landlords and others having business relations with it and
(B)keep the business and properties of the Division Business substantially
intact, including its present operations, physical facilities, working
conditions, and relationships with lessors, licensors, suppliers, customers, and
employees, and (iii) will not enter into any order, decree, judgment, or
agreement with any third party, including any governmental agency, agent,
authority, carrier, intermediary or third party payor effecting the Division
Business, directly or indirectly, except as referred to in that certain Letter
of Agreement dated as of the date hereof among the Purchaser and Seller.

          (d) Without the prior written consent of Purchaser, and without
limiting the generality of any other provision of this Agreement, Seller shall
not, with respect to the conduct of the Division Business:

               (i) incur or commit to incur any capital expenditures in
connection with the Division Business not set forth in the Disclosure Schedule
in excess of $10,000 in the aggregate;

               (ii) prepay any material obligations of the Seller in connection
with the Division Business;

               (iii) increase the compensation payable to any employee employed
in the conduct of the Division Business;
<PAGE>
               (iv) sell, transfer or otherwise dispose of any asset or property
of the Division Business except for sales of inventory in the usual and Ordinary
Course of Business and except for cash applied in payment of liabilities of the
Division Business in the usual and Ordinary Course of Business;

          (e) The Seller will not cause or permit any of its subsidiaries,
officers, directors, agents or Affiliates to (i) solicit, initiate, or encourage
the submission of any proposal or offer from any person or entity, or enter into
or consummate any transaction, relating to the acquisition of any portion of the
Purchased Assets (other than sales of inventory in the Ordinary Course of
Business) or (ii) participate in any discussions or negotiations regarding,
furnish any information with respect to, assist or participate in, or facilitate
in any other manner any effort or attempt by any person or entity to do or seek
any of the foregoing. The Seller will notify the Purchaser immediately if any
person or entity makes any proposal, offer, inquiry, or contact with respect to
any of the foregoing.

          (f) Seller shall cooperate with Purchaser, as requested by Purchaser,
so that Purchaser may obtain supplier numbers and other governmental supplier
numbers, licenses, permits, authorizations or approvals related to the Division
Business which are necessary to effectuate the avoidance of Purchaser's
successor liability for Seller's acts and omissions.

     5.3 PURCHASER'S OBLIGATIONS. The following are Purchaser's obligations:

          (a) In the event that any Permit or Environmental Permit which is to
be assigned to Purchaser is not assignable, and Purchaser deems such Permit or
Environmental Permit necessary to operate the Division Business, Purchaser shall
use its best efforts and make every good faith attempt (and Seller shall
cooperate with Purchaser) to obtain such Permit or Environmental Permit.

          (b) Purchaser shall obtain governmental supplier numbers, licenses,
permits, authorizations or approvals related to the Division Business which it
deems necessary to effectuate the avoidance of purchaser's successor liability
for Seller's acts and omissions.

     5.4 JOINT OBLIGATIONS. The following shall apply with equal force to Seller
and Purchaser:

          (a) Without implication that such laws apply to the transaction
contemplated hereby, Seller and Purchaser shall not comply with and hereby waive
the provisions of the Uniform Commercial Code or laws of any states or provinces
relating to bulk sales.

          (b) Each party shall promptly give the other party written notice of
the existence or occurrence of any condition which would make any representation
or warranty herein contained of either party untrue or which might reasonably be
expected to prevent the consummation of the transaction contemplated hereby.

          (c) No party shall intentionally perform any act which, if performed,
or omit to perform any act which, if omitted to be performed, would prevent or
excuse the performance of this Agreement by any party hereto or which would
result in any representation or warranty herein contained of said party being
<PAGE>
untrue in any material respect as if originally made on and as of the Closing
Date.

          (d) Each party shall use its respective best efforts to take, or cause
to be taken, all action and to do, or cause to be done, all things necessary,
proper or advisable to consummate the transaction contemplated hereby as soon as
possible.

                                   ARTICLE 6

                              CONDITIONS TO CLOSING

     6.1 CONDITIONS TO SELLER'S OBLIGATIONS. The obligation of Seller to
consummate the transaction contemplated hereby is subject to the fulfillment of
all of the following conditions on or prior to the Closing Date, upon the
non-fulfillment of any of which this Agreement may, at Seller's option, be
terminated pursuant to and with the effect set forth in Article XI:

          (a) Each and every representation and warranty made by Purchaser shall
be true and correct in all respects as if originally made on and as of the
Closing Date.

          (b) All obligations of Purchaser to be performed hereunder through,
and including on, the Closing Date (including, without limitation, all
obligations which Purchaser would be required to perform at the closing if the
transactions contemplated hereby were consummated) shall have been fully
performed.

          (c) No suit, proceeding or investigation shall have been commenced or
threatened by any governmental, regulatory or administrative authority on any
grounds to restrain, enjoin or hinder the consummation of the transaction
contemplated hereby or the right of the Purchaser to own the Purchased Assets or
operate the Division Business (and no order, judgment, decree or ruling shall be
in effect with respect to any such suit proceeding or investigation).

          (d) Purchaser shall have delivered to Seller (i) the written opinion
of Gadsby Hannah LLP, addressed to Seller, dated as of the Closing Date, in
substantially the form of Exhibit 6.1(d)(i) attached hereto; and (ii) the
written opinion of Goodmans LLP, addressed to Seller, dated as of the Closing
Date, in substantially the form of Exhibit 6.1(d)(ii) attached hereto.

          (e) Purchaser and Seller shall have executed the Transition Services
Agreement in substantially the form attached hereto as Exhibit 6.1(e), with such
changes therein as may be mutually acceptable to the parties (the "Transition
Services Agreement").

          (f) Seller and TegRx Pharmacy Management Co., Inc. ("Guarantor") shall
have executed the Guaranty in substantially the form annexed hereto as Exhibit
6.1(f) (the "Guaranty").

          (g) The Lockbox Agreement, in the form annexed hereto as Exhibit
6.1(g) (the "Lockbox Agreement"), shall have been executed by all parties
thereto.
<PAGE>
          (h) The sublease to the Purchaser of certain office space located at
Seller's 1275 W. Washington St., Tempe, Arizona 85281 location, pursuant to the
Transition Services Agreement, in form and substance satisfactory to the parties
(the "Sublease"), shall have been executed by Purchaser and Seller.

          (i) The Purchaser and Seller shall have delivered the Allocation
Schedules.

          (j) All actions to be taken by Purchaser in connection with the
consummation of the transactions contemplated hereby, and all certificates,
opinions, instruments and other documents of Purchaser required to effect the
transactions contemplated hereby will be reasonably satisfactory in form and
substance to the Seller.

     6.2 CONDITIONS TO PURCHASER'S OBLIGATIONS. The obligation of Purchaser to
consummate the transaction contemplated hereby is subject to the fulfillment of
all of the following conditions on or prior to the Closing Date, upon the
non-fulfillment of any of which this Agreement may, at Purchaser's option, be
terminated pursuant to and with the effect set forth in Article XI:

          (a) There shall be no Material Adverse Change in the Seller's
representations and warranties with respect to the value of the Purchased
Assets, and each and every other representation and warranty made by Seller
shall be true and correct in all respects as if originally made on and as of the
Closing Date.

          (b) All obligations of Seller to be performed hereunder through, and
including on, the Closing Date (including, without limitation, all obligations
which Seller would be required to perform at the Closing if the transaction
contemplated hereby was consummated) shall have been fully performed.

          (c) No suit, proceeding or investigation shall have been commenced or
threatened by any governmental, regulatory or administrative authority on any
grounds to restrain, enjoin or hinder the consummation of the transaction
contemplated hereby or the right of the Purchaser to own the Purchased Assets or
operate the Division Business (and no order, judgment, decree or ruling shall be
in effect with respect to any such suit proceeding or investigation).

          (d) Seller shall have delivered to Purchaser (i) the written opinion
of Quarles & Brady Streich Lang, LLP, counsel to Seller, addressed to Purchaser,
dated as of the Closing Date, in substantially the form of Exhibit 6.2(d)(i)
attached hereto; and (ii) the written opinion of Stikeman Elliott, counsel to
Seller, addressed to Purchaser, dated as of the Closing Date, in substantially
the form of Exhibit 6.2(d)(ii) attached hereto; and (iii) the written opinion of
Richards, Layton and Finger, counsel to the Seller, addressed to Purchaser,
dated as of the Closing Date, in substantially the form annexed hereto as
Exhibit 6.2(d)(iii).

          (e) Purchaser and Seller shall have executed the Transition Services
Agreement.

          (f) The Seller and Guarantor shall have executed the Guaranty.
<PAGE>
          (g) The Lockbox Agreement shall have been executed by all parties
thereto.

          (h) The Sublease shall have been executed by Purchaser and Seller.

          (i) The Seller shall have obtained the Material Consents and the
Purchaser shall have received copies of such consents to assignment in form and
substance reasonably satisfactory to the Purchaser.

          (j) The Purchaser and Seller shall have delivered the Allocation
Schedules.

          (k) The Seller have executed an election as to the sale of the
Purchased Receivables under Section 22 of the Income Tax Act (Canada)
designating in such election the applicable portion of the Purchase Price paid
by the Purchaser for the Purchased Receivables.

          (l) NCFE (as defined below) or its Affiliates shall be satisfied that
it is able to provide financing to Purchaser pursuant to that certain commitment
letter dated May 2, 2001; and Purchaser shall have received such financing at or
immediately prior to the Closing.

          (m) There shall not have been any change since the date of this
Agreement which has resulted in a Material Adverse Effect and no event has
occurred or circumstance exists that may result in such a Material Adverse
Effect.

          (n) All actions to be taken by Seller in connection with the
consummation of the transactions contemplated hereby and all certificates,
opinions, instruments and other documents of Seller required to effect the
transactions contemplated hereby will be reasonably satisfactory in form and
substance to the Purchaser.

                                    ARTICLE 7

                                     CLOSING

     7.1 FORM OF DOCUMENTS. At the Closing, the parties shall deliver the
documents, and shall perform the acts, which are set forth in this Article VII.
All documents which Seller shall deliver shall be in form and substance
reasonably satisfactory to Purchaser and Purchaser's counsel. All documents
which Purchaser shall deliver shall be in form and substance reasonably
satisfactory to Seller and Seller's counsel.

     7.2 PURCHASER'S DELIVERIES. Subject to the fulfillment or written waiver of
the conditions set forth in Section 6.2, Purchaser shall execute and/or deliver
to Seller all of the following:

          (a) the Cash Portion;

          (b) certified copies of Purchaser's Certificate of Incorporation and
By-laws;

          (c) certificates of good standing of Purchaser , issued not earlier
than ten (10) days prior to the Closing Date by the Secretary of State of
Delaware;
<PAGE>
          (d) an incumbency and specimen signature certificates with respect to
the officers of Purchaser executing this Agreement and Purchaser's Ancillary
Documents on behalf of Purchaser;

          (e) a certified copy of resolutions of each of Purchaser's board of
directors, authorizing the execution, delivery and performance of this Agreement
and Purchaser's Ancillary Documents;

          (f) a closing certificate executed by the President of Purchaser (or
any other officer of Purchaser specifically authorized to do so), on behalf of
Purchaser, pursuant to which Purchaser represents and warrants to Seller that
Purchaser's representations and warranties to Seller are true and correct as of
the Closing Date as if then originally made (or, if any such representation or
warranty is untrue in any respect specifying the respect in which the same is
untrue), that all obligations or covenants required by the terms hereof to be
performed by Purchaser on or before the Closing Date, to the extent not waived
in writing by Seller, have been so performed (or, if any such covenant has not
been performed, indicating that such covenant has not been performed), and that
all documents to be executed and delivered by Purchaser at the Closing have been
executed by duly authorized officers of Purchaser;

          (g) such other documents from Purchaser as may reasonably be required
in order to effectuate the transactions contemplated (i) hereby and (ii) by the
Purchaser's Ancillary Documents.

     7.3 SELLER'S DELIVERIES. Subject to the fulfillment or written waiver of
the conditions set forth in Section 6.1, Seller shall deliver to Purchaser
physical possession of all tangible Purchased Assets, and shall execute (where
applicable in recordable form) and/or deliver or cause to be executed and/or
delivered to Purchaser all of the following:

          (a) certified copies of OrthoLogic's Certificate of Incorporation and
By-laws and certified copies of OrthoCanada's Certificate of Incorporation and
By-laws;

          (b) certificates of good standing of OrthoLogic, issued not earlier
than ten (10) days prior to the Closing Date by the Secretaries of State of
Delaware and Arizona, and a certificate of compliance of OrthoCanada, issued not
earlier than ten (10) days prior to the Closing Date by Industry Canada;

          (c) incumbency and specimen signature certificates with respect to the
officers of Seller executing this Agreement and Seller's Ancillary Documents on
behalf of Seller;

          (d) certified copies of resolutions of Seller's board of directors
authorizing the execution, delivery and performance of this Agreement and
Seller's Ancillary Documents;

          (e) a bill of sale, executed by Seller, conveying all of the tangible
personal property included in the Purchased Assets to Purchaser (the "Bill of
Sale");

          (f) an assignment to Purchaser, executed by Seller, assigning to
Purchaser all of the Purchased Assets (other than tangible personal property),
along with the original instruments (if any) representing, evidencing or
<PAGE>
constituting such Purchased Assets (the "Assignment"). To the extent necessary
in the reasonable opinion of Purchaser's counsel, Seller shall also execute and
deliver (in recordable form where required) separate assignments of any of such
Purchased Assets, and where applicable, in the form reasonably required by the
applicable governmental agencies, insurance companies, customers, lessors and
other parties with whom the assignments must be filed;

          (g) a closing certificate duly executed by the President of Seller (or
any other officer of Seller specifically authorized to do so), on behalf of
Seller, pursuant to which Seller represents and warrants to Purchaser that: (i)
Seller's representations and warranties to Purchaser other than Section 4.3(l)
are true and correct as of the Closing Date as if then originally made, and that
the representations and warranties contained in Section 4.3(l) are true and
correct as of the Closing Date as if then originally made except that Schedule
4.3(l) of the Disclosure Schedule has not been updated to reflect non-material
changes thereto occurring in the Ordinary Course of Business between the date
hereof and the Closing Date (or, if any such representation or warranty is
untrue in any respect, specifying the respect in which the same is untrue); (ii)
all obligations or covenants required by the terms hereof to be performed by
Seller on or before the Closing Date, to the extent not waived in writing by
Purchaser, have been so performed (or, if any such covenant has not been so
performed, indicating that such covenant has not been performed); and (iii) all
documents to be executed and delivered by Seller at the Closing have been
executed by duly authorized officers of Seller;

          (h) copies of the Material Consents which have been obtained;

          (i) copies of all governmental licenses, permits, and other approvals
and accreditations which are being transferred pursuant to this Agreement;

          (j) certificates of title or origin (or like documents) with respect
to all vehicles included in the Purchased Assets and other Equipment for which a
certificate of title or origin is required in order for title thereto to be
transferred to Purchaser; and

such other documents as may reasonably required from Seller in order to
effectuate the transactions contemplated (i) hereby and (ii) by the Seller's
Ancillary Documents.

                                   ARTICLE 8

                             POST-CLOSING AGREEMENTS

     8.1 POST-CLOSING AGREEMENTS. From and after the Closing, the parties shall
have the respective rights and obligations which are set forth in the remainder
of this Article VIII.

     8.2 INSPECTION OF RECORDS. Seller and Purchaser shall each make their
respective books and records (including work papers in the possession of their
respective accountants) available for inspection by the other party, or by its
duly accredited representatives, for reasonable business purposes at all
reasonable times during normal business hours, for a five (5) year period after
the Closing Date, with respect to all transactions of the Division Business
occurring prior to and those relating to the Closing, the historical financial
condition, results of operations and cash flows of the Division Business, or the
Assumed Liabilities. In the case of records owned by Seller, such records shall
<PAGE>
be made available at Seller's executive office, and in the case of records owned
by Purchaser, such records shall be made available at Purchaser's executive
office. As used in this Section 8.2, the right of inspection includes the right
to make extracts or copies. The representatives of a party inspecting the
records of the other party shall be reasonably satisfactory to the other party.
In addition, in connection with lawsuits or other proceedings, Seller or
Purchaser, as the case may be, shall use reasonable efforts to make available at
the requesting party's expense, personnel (for reasonable periods of time) of
Seller or Purchaser, as the case may be, for purposes of depositions and
testimony. In addition, Purchaser shall give reasonable assistance to Seller
(for reasonable periods of time), through Purchaser's employees, to obtain such
access in order for Seller to record entries relating to the closing of Seller's
books relating to the Division Business, to prepare and file Tax returns related
to the Division Business, and to prepare the Closing Balance Sheet. Each party
shall bear its own costs and expenses with respect to such assistance.

     8.3 USE OF TRADEMARKS. Seller shall cease to use and shall not license or
permit any third party to use the name "OrthoRehab", or any name, slogan, logo
or trademark which is similar or deceptively similar to any of the Trademarks.

     8.4 PAYMENTS OF ACCOUNTS RECEIVABLE. ON OR IMMEDIATELY FOLLOWING THE
CLOSING DATE, THE SELLER SHALL SEND TO EACH PAYOR OF AN ELIGIBLE PURCHASED
RECEIVABLE A NOTICE, IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO NCFE (AS
DEFINED BELOW), WHICH SHALL DIRECT SUCH PAYOR TO REMIT ALL PAYMENTS WITH RESPECT
TO SUCH PURCHASED RECEIVABLE FOR DEPOSIT IN THE LOCKBOX ACCOUNT. DURING THE
PERIOD FROM THE CLOSING DATE UNTIL THE FIRST ANNIVERSARY OF THE CLOSING DATE
(THE "ACCOUNTS RECEIVABLE TRANSITION PERIOD"), DISBURSEMENTS FROM SELLER'S
LOCKBOX ACCOUNTS SHALL TAKE PLACE ACCORDING TO THE PROCEDURES SET FORTH IN THE
LOCKBOX AGREEMENT AND EXHIBITS THERETO. FROM AND AFTER THE CLOSING DATE, (I)IN
THE EVENT SELLER SHALL RECEIVE ANY INSTRUMENT OF PAYMENT OF ANY OF THE PURCHASED
RECEIVABLES, SELLER SHALL DELIVER IT TO PURCHASER, ENDORSED WHERE NECESSARY,
WITHOUT RECOURSE, IN FAVOR OF PURCHASER AND (II)IN THE EVENT PURCHASER SHALL
RECEIVE ANY INSTRUMENT OF PAYMENT OF ANY RECEIVABLE OF SELLER THAT IS NOT A
PURCHASED RECEIVABLE, PURCHASER SHALL DELIVER IT TO SELLER, ENDORSED WHERE
NECESSARY, WITHOUT RECOURSE, IN FAVOR OF SELLER. FROM TIME TO TIME DURING THE
ACCOUNTS RECEIVABLE TRANSITION PERIOD, PURCHASER AND SELLER SHALL COOPERATE TO
DETERMINE WHICH OF PURCHASER OR SELLER IS ENTITLED TO ANY OF THE UNMATCHED
REMITTANCES (AS DEFINED IN THE LOCKBOX AGREEMENT). IF PURCHASER AND SELLER ARE
UNABLE TO DETERMINE WHICH OF THEM IS ENTITLED TO ANY UNMATCHED REMITTANCE AND
SUCH UNMATCHED REMITTANCE(S) IS LESS THAN $10,000 IN THE AGGREGATE, PURCHASER
AND SELLER AGREE THAT EACH OF THEM SHALL BE ENTITLED TO ONE HALF OF SUCH
UNMATCHED REMITTANCE(S). IF PURCHASER AND SELLER ARE UNABLE TO DETERMINE WHICH
OF THEM IS ENTITLED TO ANY UNMATCHED REMITTANCE AND SUCH UNMATCHED REMITTANCE(S)
GREATER THAN OR EQUAL TO $10,000 IN THE AGGREGATE, PURCHASER AND SELLER AGREE
THEY SHALL SUBMIT SUCH INFORMATION REGARDING SUCH UNMATCHED REMITTANCES AS IS IN
EACH OF THEIR POSSESSION TO A NATIONALLY RECOGNIZED FIRM OF CERTIFIED PUBLIC
ACCOUNTANTS (A "CPA FIRM") AND AGREE TO BE BOUND BY THE DETERMINATION OF SUCH
CPA FIRM AS TO WHICH PORTION OF SUCH UNMATCHED REMITTANCE(S) EACH OF PURCHASER
AND SELLER IS ENTITLED. PURCHASER AND SELLER SHALL EACH PAY ONE HALF OF THE FEES
OF SUCH CPA FIRM. UPON ANY SUCH DETERMINATION DESCRIBED ABOVE, WHETHER BY
AGREEMENT OF PURCHASER AND SELLER OR BY A DECISION OF A CPA FIRM, PURCHASER AND
SELLER SHALL PROMPTLY AUTHORIZE BANK (AS DEFINED IN THE LOCKBOX AGREEMENT) TO
<PAGE>
MAKE SUCH DISBURSEMENTS AS ARE APPROPRIATE, BASED ON SUCH DETERMINATION, FROM
THE JOINT ACCOUNT (AS DEFINED IN THE LOCKBOX AGREEMENT).

     8.5 THIRD PARTY CLAIMS. The parties shall cooperate with each other with
respect to the defense of any claims or litigation made or commenced by third
parties subsequent to the Closing Date which are not subject to the
indemnification provisions contained in Article X, provided that the party
requesting cooperation shall reimburse the other party for the other party's
reasonable out-of-pocket costs and expenses of furnishing such cooperation.

     8.6 POST CLOSING CONSENTS. For a period of nine months from the Closing
Date, Seller shall use its best efforts and make every good faith attempt (and
Purchaser shall cooperate with Seller) to obtain the consents to the assignment
of the agreements described in Section 1.2(d), (i), (j), (l) and (q) or any
other consents that are required to transfer any of the Purchased Assets to the
Purchaser.

     8.7 NON-ASSIGNMENT. Notwithstanding any provision to the contrary contained
herein (but not in limitation of Seller's obligations under Section 5.2(b)),
Seller shall not be obligated to assign to Purchaser any contract, purchase
order, sales order, lease or other instrument which provides that it may not be
assigned without the consent of the other party thereto and for which such
consent is not obtained, but in any such event, Seller shall, to the extent
necessary and at each party's respective cost, cooperate with Purchaser in any
necessary arrangement designed to provide the benefits thereof to Purchaser.
Without limiting the generality of any provision elsewhere herein contained, the
non-assignment of any of the foregoing shall not, to the extent the liabilities
thereunder would have been Assumed Liabilities but for this Section 8.7, affect
the status of such liabilities as Assumed Liabilities.

     8.8 COLLECTION EFFORTS. Purchaser shall use its best efforts and make every
good faith attempt commensurate with Seller's historical practices to collect
all of the Purchased Receivables on or prior to the first anniversary of the
Closing Date. Purchaser shall provide Seller reasonable access to its books and
records with respect to the collection of such Purchased Receivables at least
quarterly during normal business hours, with at least seven (7) business days'
prior written notice, to verify such collection efforts. Purchaser shall be
permitted to use the names "OrthoLogic" and "OrthoLogic Canada" in such
collection efforts and shall be deemed to be granted a license for such purpose
hereunder.

     8.9 LABELING OF PRODUCTS. Within one (1) year following the Closing Date,
Purchaser shall remove to the extent practicable the name "OrthoLogic,"
"OrthoLogic Canada" or any similar name from Products, packaging materials, or
promotional materials that exist as of the Closing Date. Purchaser shall be
deemed to have a license to use such names on such Products and materials during
such period of time. Nothing contained herein shall exclude Purchaser from using
the name "OrthoRehab" or "OrthoRehab, Inc." on such Products or materials or
otherwise in its business. Such name is being transferred to Purchaser pursuant
to Section 1.2(k) hereof.
<PAGE>
     8.10 SELLER OBLIGATIONS. Seller agrees to be responsible for and pay any
obligations arising out of the Excluded Liabilities. Seller agrees to pay all
sales, use and transfer taxes on the transfer of the Purchased Assets hereunder.

     8.11 CONFIDENTIALITY. The Seller will treat and hold as such all of the
Confidential Information, refrain from using any of the Confidential Information
except in connection with this Agreement, and deliver promptly to the Purchaser
or destroy, at the request and option of the Purchaser, all tangible embodiments
(and all copies) of the Confidential Information which are in his or its
possession. In the event that the Seller is requested or required (by oral
question or request for information or documents in any legal proceeding,
interrogatory, subpoena, civil investigative demand, or similar process) to
disclose any Confidential Information, Seller will notify the Purchaser promptly
of the request or requirement so that the Purchaser may seek an appropriate
protective order or waive compliance with the provisions of this section. If, in
the absence of a protective order or the receipt of a waiver hereunder, the
Seller is, on the advice of counsel, compelled to disclose any Confidential
Information to any tribunal or else stand liable for contempt, the Seller may
disclose the Confidential Information to the tribunal; provided, however, that
the Seller shall use its best efforts to obtain, at the request of the
Purchaser, an order or other assurance that confidential treatment will be
accorded to such portion of the Confidential Information required to be
disclosed as the Purchaser shall designate. For the purpose of this section,
"Confidential Information" means any and all information concerning the
businesses and affairs of the Division Business other than that information
which is already generally or readily obtainable by the public or is publicly
known or becomes publicly known through no fault of the Sellers. The Seller also
agrees that it shall cause its directors and officers to comply with this
Section 8.11 for a period of one (1) year after the Closing Date and shall be
responsible for any breach of this Section 8. 11 by such officers and directors.
The Seller also agrees it shall use its reasonable best efforts to cause its
employees to comply with this Section 8.11 for a period of one (1) year after
the Closing Date.

     8.12 NONCOMPETITION.

          (a) The Seller agrees that, in consideration of the purchase by
Purchaser hereunder and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, it shall not, on or prior to the
date which is five (5) years after the Closing Date, directly or indirectly,
own, manage, operate, control, be employed by, provide consulting services to,
participate in, lend its name to, invest in or be connected in any manner with
the management, ownership, operation or control of any business, venture, or
activity which competes with the Products (including parts and accessories
therefore or any aspect of the Division Business). The Seller also agrees that
it shall cause its directors and officers to comply with this Section 8.12(a)
for a period of one (1) year after the Closing Date and shall be responsible for
any breach of this Section 8. 12(a) by such officers and directors. The Seller
also agrees it shall use its reasonable best efforts to cause its employees to
comply with this Section 8.12(a) for a period of one (1) year after the Closing
Date.

          (b) Seller further agrees that for a period of five (5) years after
the Closing Date it will not directly or indirectly without the prior written
consent of Purchaser, recruit, offer employment, employ, engage as a consultant,
lure or entice away or in any other manner persuade or attempt to persuade any
person who is an employee of the Purchaser or any subsidiary, group, or division
<PAGE>
of Purchaser or any Affiliate thereof (including the Division Business), to
leave the employ of Purchaser unless such person has been terminated by the
Purchaser or an Affiliate of Purchaser. The Seller also agrees that it shall
cause its directors and officers to comply with this Section 8.12(b) and shall
be responsible for any breach of this Section 8. 12(b) by such officers and
directors. The Seller also agrees it shall use its reasonable best efforts to
cause its employees to comply with this Section 8.12(b) for a period of one (1)
year after the Closing Date.

With respect to OrthoCanada's officers, directors and employees, the
noncompetition provisions referred to above shall apply only in the country of
Canada and its provinces and territories.

     8.13 FURTHER ASSURANCES. At any time and from time to time after the
Closing, at the request of Purchaser and without further consideration, except
as stated below, Seller will execute and deliver such other instruments of sale,
transfer, conveyance, assignment and confirmation and take such action as
Purchaser may reasonably determine is necessary to transfer, convey and assign
to Purchaser, and to confirm Purchaser's title to or interest in the Purchased
Assets, to put Purchaser in actual possession and operating control thereof and
to assist Purchaser in exercising all rights with respect thereto. The Seller
hereby constitutes and appoints Purchaser and its successors and assigns as its
true and lawful attorney in fact in connection with the transactions
contemplated by this instrument, with full power of substitution, in the name
and stead of the Seller but on behalf of and for the benefit of the Purchaser
and its successors and assigns, to demand and receive any and all of the assets,
properties, rights and business hereby conveyed, assigned, and transferred or
intended so to be, and to give receipt and releases for and in respect of the
same and any part thereof, and from time to time to institute and prosecute, in
the name of the Seller or otherwise, for the benefit of the Purchaser or its
successors and assigns, proceedings at law, in equity, or otherwise, which the
Purchaser or its successors or assigns reasonably deem proper in order to
collect or reduce to possession or endorse any of the Purchased Assets and to do
all acts and things in relation to the assets which the Purchaser or its
successors or assigns reasonably deem desirable.

                                    ARTICLE 9

                                    EMPLOYEES

     9.1 EMPLOYMENT OF SELLER'S EMPLOYEES. On or before the Closing Date,
Purchaser shall offer to employ as of the Closing Date at least 75% of Seller's
employees employed in the conduct of the Division Business, as listed on
SCHEDULE 9.1, in positions, at compensation, and upon terms and conditions which
are for each employee similar and no less favorable in the aggregate to the
employees than the position, compensation, and terms or conditions in effect on
the date hereof. Each such person who is employed by Purchaser is hereinafter
referred to individually as a "Transferred Employee" and collectively as the
"Transferred Employees". Each such person who is not employed by Purchaser is
hereinafter referred to individually as a Non-Transferred Employee and
collectively as the "Non-Transferred Employees". Purchaser shall only be
required to offer benefits to such Transferred Employees consistent with
Purchaser's current benefit plans; provided that Purchaser shall cover all
Transferred Employees with group medical benefits for which all waiting periods
and pre-existing condition exceptions are waived, to the extent permitted under
Purchaser's existing insurance coverage. Following the Closing, Purchaser shall
<PAGE>
be entitled to change its benefit plans in the Ordinary Course of Business.
Except for voluntary resignations and deaths, Purchaser shall continue to employ
each Transferred Employee until at least the last day of the first full calendar
month commencing after the Closing Date, but may at any time terminate any
Transferred Employee for cause. Purchaser agrees to allow Transferred Employees
to roll over their benefits from Seller's 401(k) Plan into its own 401(k) Plan
or other tax qualified retirement plan. Purchaser shall have no liabilities or
obligations with respect to Non-Transferred Employees, and such liabilities and
obligations shall be considered Excluded Liabilities hereunder.

     9.2 SELLER OBLIGATIONS. The Seller agrees to (i) terminate the employment
of all of the Transferred Employees immediately prior to Closing and to pay (and
provide Purchaser with reasonable proof of payment of) any and all liabilities
relating to such termination of employment, including, without limitation any
payments and benefits due such Transferred Employees pursuant to accrued salary,
wages and other compensation, accrued vacation pay, pension, retirement,
savings, health, welfare and other benefits and termination or severance
payments or similar payments due to the Transferred Employees by statute,
contract, and common law (unless such payments are being assumed by the
Purchaser pursuant to Section 2.2(b)) and (ii) provide to all Transferred
Employees any notice (which notice shall be reasonably acceptable to Purchaser)
required under any law or regulations in respect of such termination including,
without limitation COBRA. Seller agrees to provide COBRA continuation health
coverage to all employees of the OrthoLogic Division Business and their related
qualified beneficiaries who become entitled to COBRA coverage on or before the
Closing at such employee's cost. Seller agrees to terminate participation of
Transferred Employees in its 401(k) plan as of the Closing and cause to
distribute promptly account balances to Transferred Employees. Seller agrees to
facilitate direct rollovers of 401(k) balances to Purchaser's 401(k) or other
tax qualified retirement plan. Seller agrees to request that Transferred
Employees execute a release of all obligations arising from the employment and
termination of employment of Transferred Employees with the Division Business in
consideration for the payments to be made to the Transferred Employees, in a
form reasonably satisfactory to Purchaser, and to assign the benefit of any
executed release to the Purchaser.

                                   ARTICLE 10

                                 INDEMNIFICATION

     10.1 GENERAL. From and after the Closing, the parties shall indemnify each
other as provided in this Article X.

     10.2 CERTAIN DEFINITIONS. As used in this Agreement, the following terms
shall have the indicated meanings:

          (a) "Damages" shall mean all assessments, levies, losses, fines,
penalties, damages, costs and expenses, including, without limitation,
reasonable attorneys', accountants', investigators', and experts' fees and
expenses;

          (b) "Indemnified Party" shall mean a party hereto who is entitled to
indemnification from another party hereto pursuant to this Article X;
<PAGE>
          (c) "Indemnifying Party" shall mean a party hereto who is required to
provide indemnification under this Article X to another party hereto;

          (d) "Third Party Claim" shall mean any action, suit, proceeding,
investigation or like matter which is asserted or threatened by a party other
than the parties hereto, their successors and permitted assigns, against any
Indemnified Party or to which an Indemnified Party is subject.

     10.3 INDEMNIFICATION OBLIGATIONS OF SELLER. Subject to the provisions of
Sections 10.4 and 10.8, Seller shall indemnify, save and keep harmless
Purchaser, its Affiliates, directors, officers, employees, agents, and its
successors and permitted assigns and National Century Financial Enterprises,
Inc. ("NCFE") or its Affiliates ("Purchaser Indemnitees") against and from all
Damages sustained or incurred by any of them resulting from or arising out of or
by virtue of:

          (a) any inaccuracy in or breach of any representation and warranty
made by Seller in this Agreement or in any closing document delivered to
Purchaser in connection with this Agreement;

          (b) any breach by Seller of, or failure by Seller to comply with, any
of its covenants or obligations under this Agreement (including, without
limitation, its obligations under this Article X); and

          (c) the failure to discharge when due any liability or obligation
(including without limitation any Excluded Liability) of Seller other than the
Assumed Liabilities.

     10.4 LIMITATION ON SELLER'S INDEMNIFICATION OBLIGATIONS.

          (a) Seller's indemnification obligations pursuant to the provisions of
Section 10.3 shall continue following the Closing Date for the applicable
statute of limitations period, PROVIDED THAT if such claim or Third Party Claim
for Damages relates to either (i) a claim for breach of Seller's representations
or warranties arising under Section 10.3(a) hereof ("Representation and Warranty
Claims"), (ii) the dollar value of the inventory described in Section 1.2(a) (an
"Inventory Claim") or (iii) the dollar value of the rental fleet described in
Section 1.2(f) (a "Rental Fleet Claim"), a Purchaser Indemnitee must assert such
claim prior to the expiration of (x) the one (1) year anniversary of the Closing
Date for Representation and Warranty Claims, (y) sixty (60) days following the
Closing Date for Inventory Claims and (z) ninety (90) days following the Closing
Date for Rental Fleet Claims.

          (b) Purchaser Indemnitees shall not be entitled to recover for
Representation and Warranty Claims (including Inventory Claims and Rental Fleet
Claims) in excess of $1,000,000; provided, however, that such limitation shall
in no event prevent such Purchaser Indemnitees from bringing or recovering for
any claim for any amount that might also apply to any other provision of Section
10.3, regardless of whether such claim might also be considered to be a
Representation and Warranty Claim (or an Inventory Claim or Rental Fleet Claim).

          (c) The Purchaser Indemnitees shall not be entitled to recover under
Section 10.3: (i) with respect to the nonassignability or nontransferability of
any of the contracts or agreements listed on SCHEDULE 1.2(I), SCHEDULE 1.2(J),
<PAGE>
and SCHEDULE 1.2(L), or the failure to obtain any consent required in connection
with the assignment or transfer of any such contracts or agreements; provided,
however, that the Seller shall use its best efforts following the Closing to
assign or transfer all such contracts or agreements to Purchaser and to obtain
any consent required in connection with such assignment or transfer; (ii) to the
extent that such Damages are actually paid for by insurance proceeds, net of any
and all direct or indirect costs incurred by Purchaser in connection with such
payment, including but not limited to, subsequent insurance premium increases;
or (iii) with respect to any claim to the extent it relates to the value of or
the collection of the Purchased Receivables, which shall be governed by Section
3.3(c); provided, however, that Purchaser may set-off the amount of any
Representation and Warranty Claim against any Contingent Payment Amount due to
Seller.

          (d) With respect to claims arising under, in connection with, or with
respect to this Agreement, Purchaser Indemnitees shall only be entitled to seek
indemnification from Seller pursuant to provisions of this Article X, except
with respect to claims or actions for equitable or injunctive relief or specific
performance or for fraud or similar claims.

     10.5 PURCHASER'S INDEMNIFICATION COVENANTS. Purchaser shall indemnify, save
and keep harmless Seller its Affiliates, directors, officers, employees and
agents, and its successors and permitted assigns ("Seller Indemnitees") against
and from all Damages sustained or incurred by any of them resulting from or
arising out of or by virtue of:

          (a) any inaccuracy in or breach of any representation and warranty
made by Purchaser in this Agreement or in any closing document delivered to
Seller in connection with this Agreement;

          (b) any breach by Purchaser of, or failure by Purchaser to comply
with, any of its covenants or obligations under this Agreement (including,
without imitation, its obligations under this Article X);

          (c) Purchaser's failure to pay, discharge and perform any of the
Assumed Liabilities when due; or

          (d) acts or omissions of Purchaser after the Closing Date and not
constituting an Excluded Liability, including, without limitation, Purchaser's
operation of the Division Business after the Closing Date (provided that such
circumstances do not arise from Seller's breach of this Agreement).

     10.6 COOPERATION. Subject to the provisions of Section 10.7, the
Indemnifying Party shall have the right, at its own expense, to participate in
the defense of any Third Party Claim, and if said right is exercised, the
parties shall cooperate in the investigation and defense of said Third Party
Claim.

     10.7 THIRD PARTY CLAIMS. Except as otherwise provided in this Section 10.7,
forthwith following the receipt of notice of a Third Party Claim, the party
receiving the notice of the Third Party Claim shall (i) notify the other party
of its existence setting forth with reasonable specificity the facts and
circumstances of which such party has received notice, and (ii) if the party
giving such notice is an Indemnified Party, specifying the basis hereunder upon
which the Indemnified Party's claim for indemnification is asserted. The
<PAGE>
Indemnified Party may, upon reasonable notice, tender the defense of a Third
Party Claim to the Indemnifying Party. If:

          (a) the defense of a Third Party Claim is so tendered and within
thirty (30) days thereafter such tender is accepted without qualification by the
Indemnifying Party; or

          (b) within thirty (30) days after the date on which written notice of
a Third Party Claim has been given pursuant to this Section 10.7, the
Indemnifying Party shall acknowledge without qualification its indemnification
obligations as provided in this Article X in writing to the Indemnified Party;

then, except as hereinafter provided, the Indemnified Party shall not, and the
Indemnifying Party shall, have the right to contest, defend, litigate or settle
such Third Party Claim. The Indemnified Party shall have the right to be
represented by counsel at its own expense in any such contest, defense,
litigation or settlement conducted by the Indemnifying Party provided that the
Indemnified Party shall be entitled to reimbursement therefore if the
Indemnifying Party shall lose its right to contest, defend, litigate and settle
the Third Party Claim as herein provided. The Indemnifying Party shall lose its
right to contest, defend, litigate and settle the Third Party Claim if it shall
fail to diligently contest the Third Party Claim. So long as the Indemnifying
Party has not lost its right and/or obligation to contest, defend, litigate and
settle as herein provided, the Indemnifying Party shall have the exclusive right
to contest, defend and litigate the Third Party Claim and shall have the
exclusive right, in its discretion exercised in good faith, and upon the advice
of counsel, to settle any such matter, either before or after the initiation of
litigation, at such time and upon such terms as it deems fair and reasonable,
provided that at least ten (10) days prior to any such settlement, written
notice of its intention to settle shall be given to the Indemnified Party. All
expenses (including without limitation attorneys' fees) incurred by the
Indemnifying Party in connection with the foregoing shall be paid by the
Indemnifying Party. No failure by an Indemnifying Party to acknowledge in
writing its indemnification obligations under this Article X shall relieve it of
such obligations to the extent they exist. If an Indemnified Party is entitled
to Indemnification against a Third Party Claim, and the Indemnifying Party fails
to accept a tender, or assume the defense, of a Third Party Claim pursuant to
this Section 10.7, or if, in accordance with the foregoing, the Indemnifying
Party shall lose its right to contest, defend, litigate and settle such a Third
Party Claim, the Indemnified Party shall have the right, without prejudice to
its right of indemnification hereunder, in its discretion exercised in good
faith and upon the advice of counsel, to contest, defend and litigate such Third
Party Claim, and may settle such Third Party Claim, either before or after the
initiation of litigation, at such time and upon such terms as the Indemnified
Party deems fair and reasonable, provided that at least ten (10) days prior to
any such settlement, written notice of its intention to settle is given to the
Indemnifying Party. If, pursuant to this Section 10.7, the Indemnified Party so
contests, defends, litigates or settles a Third Party Claim for which it is
entitled to indemnification hereunder, as hereinabove provided, the Indemnified
Party shall be reimbursed by the Indemnifying Party for the reasonable
attorneys' fees and other expenses of defending, contesting, litigating and/or
settling the Third Party claim which are incurred from time to time, forthwith
following the presentation to the Indemnifying Party of itemized bills for said
attorneys' fees and other expenses.
<PAGE>
         Notwithstanding the forgoing, Seller shall not have such an exclusive
right to contest, defend, litigate and settle any Third Party Claim against
Seller arising from or related to any action, audit, investigation, prosecution,
assessment, agreement or other undertaking by any government agency, authority,
agent, carrier, intermediary or any third party payor, and the right to contest,
defend, litigate and settle of any such Third Party Claim and to determine its
manner shall be jointly determined in good faith by Seller and Purchaser.

                                   ARTICLE 11

                        EFFECT OF TERMINATION/PROCEEDING

     11.1 GENERAL. The parties shall have the rights and remedies with respect
to the termination and/or enforcement of this Agreement which are set forth in
this Article XI.

     11.2 RIGHT TO TERMINATE. This Agreement and the transactions contemplated
hereby may be terminated at any time prior to the Closing by prompt notice given
in accordance with Section 13.4:

          (a) by the mutual written consent of Purchaser and Seller; or

          (b) by either of such parties if the Closing shall not have occurred
at or before 11:59 p.m. Eastern Standard Time on forty-fifth (45th) day
following the date of this Agreement (the "Outside Date"), provided, however,
that the right to terminate this Agreement under this Section 11.2(b) shall not
be available to any party whose breach of representation or warranty or failure
to fulfill any of its obligations under this Agreement has been the cause of or
resulted in the failure of the Closing to occur on or prior to the aforesaid
date.

     11.3 CERTAIN EFFECTS OF TERMINATION. In the event of the termination of
this Agreement by either Seller or Purchaser as provided in Section 11.2:

          (a) each party, if so requested by the other party, will return
promptly every document furnished to it by the other party (or any subsidiary,
division, associate or Affiliate of such other party) in connection with the
transaction contemplated hereby, whether so obtained before or after the
execution of this Agreement, and any copies thereof (except for copies of
documents publicly available) which may have been made, and will use reasonable
efforts to cause its representatives and any representatives of financial
institutions and investors and others to whom such documents were furnished
promptly to return such documents and any copies thereof any of them may have
made;

          (b) all information received by any party hereto with respect to the
business of the other party hereto or its subsidiaries, divisions, Affiliates or
associates (other than information which is a matter of public knowledge or
which has heretofore been or is hereafter publicly published in any publication
for public distribution or filed as public information with any governmental
authority) shall not, unless otherwise required by law, at any time be used for
the advantage of, or disclosed to third parties by, such party for any reason
whatsoever.

This Section 11.3 shall survive any termination of this Agreement.
<PAGE>
     11.4 REMEDIES. Notwithstanding any termination right granted in Section
11.2, in the event of the breach of any representation or warranty or the
nonfulfillment of any condition to a party's closing obligations which has not
been cured by such party by the Outside Date, in the alternative, the other
party hereto may elect to do one of the following:

          (a) proceed to close despite the breach of any representation or
warranty or the nonfulfillment of any closing condition, it being understood
that consummation of the Closing shall be deemed a waiver of each breach of any
representation, warranty or covenant and of such party's rights and remedies
with respect thereto to the extent that such party shall have actual knowledge
of such breach and the Closing shall nonetheless occur;

          (b) decline to close, terminate this Agreement as provided in Section
11.2, and thereafter seek damages to the extent permitted in Section 11.5; or

          (c) seek specific performance of the obligations of the other party.
Each party hereby agrees that in the event of any breach by such party of this
Agreement, the remedies available to the other party at law would be inadequate
and that such party's obligations under this Agreement may be specifically
enforced.

     11.5 RIGHT TO DAMAGES. If this Agreement is terminated pursuant to Section
11.2 or 11.4(b), neither party hereto shall have any claim against the other
except if the circumstances giving rise to such termination were caused by the
other party's breach of representation or warranty or failure to comply with a
covenant or obligation set forth herein, in which event termination pursuant to
Section 11.2 or 11.4(b) shall not be deemed or construed as limiting or denying
any legal or equitable right or remedy of said non-breaching party, and said
non-breaching party shall also be entitled to recover its actual costs and
expenses which are incurred in pursuing its rights and remedies (including
reasonable attorneys' fees).

                                   ARTICLE 12

                                 PAYOR CONTRACTS

     12.1 TRANSFER AND ASSIGNMENT. With respect to the third party payor
contracts listed on SCHEDULE 12.1 attached hereto, which are being transferred
to Purchaser but for which consent to assignment has not been obtained from such
third party by the Closing Date ("Third Party Payor Contracts"), Seller hereby
agrees to initially assign and transfer each Third Party Payor Contract and
Purchaser hereby agrees to initially assume each such Third Party Payor Contract
as it relates to the Division Business. The final assignment of each Third Party
Payor Contract is contingent upon (i) the assent of the Payor, or other
authorized party, to the assignment to the Purchaser, or the issuance by the
Payor of a new contract to the Purchaser; and (ii) the final ratification and
acceptance of the Third Party Payor Contract assignment by the Purchaser or the
execution by the Purchaser of a new contract issued by the Payor ("Final
Contract Assignment"). Upon such Final Contract Assignment, Seller hereby agrees
to an irrevocable termination of its rights under to each such Third Party Payor
Contract with respect to the Division Business.

     12.2 NOTICE TO PAYORS. Seller shall provide notice to each Payor within 10
days of the Closing Date that it has definitively agreed to transfer the
Division Business functions and enrollment under the Third Party Payor Contract
<PAGE>
to the Purchaser and that the contractual relationship between the Seller and
the Payor with respect to the Division Business shall terminate upon Final
Contract Assignment to the Purchaser (the "Payor Contract Termination Date").

     12.3 PURCHASER'S OBLIGATIONS. Purchaser shall assume Seller's obligations
related exclusively to the Division Business as may accrue from and after the
Closing Date under each Third Party Payor Contract its own expense.

     12.4 POWER OF ATTORNEY. Seller hereby appoints Purchaser (and any
subcontractor designated by Purchaser) as its lawful attorney-in-fact for
purposes of the following actions with regard to each portion of a Third Party
Payor Contract with respect to the Division Business and each Purchased
Receivable after the Closing Date:

          (a) BILLING. To bill in Seller's name using its provider numbers and
on Seller's behalf all charges and reimbursements for all goods and services
provided to patients;

          (b) COLLECTIONS. To collect all revenue from whatever source,
including the Purchased Receivables due in connection with such portion of a
Third Party Payor Contract with respect to the Division Business ("Third Party
Payor Collections"), and to receive all such collections on Seller's behalf and
to sue for and give satisfaction for monies due on account and to withdraw any
claims, suits or proceedings pertaining to or arising out of Purchaser's or
Seller's right to collect such accounts;

          (c) ENDORSEMENT. To take possession of and endorse in Seller's name
any notes, checks, money orders, insurance payments and any other instruments
received as Collections;

          (d) BANKING POWERS. To deposit all Collections directly into a bank
account subject to the Lockbox Agreement and make disbursement in accordance
therewith;

          (e) PATIENT INFORMATION. To contact and gather information from any
patient for whom services have been provided that has resulted in a Purchased
Receivable; and

          (f) OTHER ACTIONS. Perform all other actions reasonably necessary to
bill and collect amounts due or which would be due upon billing of the Purchased
Receivables.

          Seller hereby ratifies all that said attorneys shall lawfully do or
cause to be done by virtue hereof. This power of attorney is a power coupled
with an interest and shall be irrevocable.

                                   ARTICLE 13

                                  MISCELLANEOUS

     13.1 SALES AND TRANSFER TAXES. Seller shall pay all sales, use, transfer
and conveyance taxes arising in connection with the sale and transfer of the
Purchased Assets to Purchaser pursuant to this Agreement.
<PAGE>
     13.2 DEFINITION OF BEST EFFORTS. Except as otherwise specifically provided
in this Agreement, for purposes of this Agreement, the phrases "best efforts"
and "best efforts to cause," when used with reference to efforts to be made by a
party hereto or any of its Affiliates:

          (a) shall not require such party or any of its Affiliates to pay or
transfer any money, property or other thing of value to any other party except
routine charges for filing or recording fees, and courier and other
communication services;

          (b) shall require such party and its Affiliates to act with all
reasonable promptness and dispatch with respect thereto; and

          (c) shall require the other party and its Affiliates to act with all
reasonable promptness and dispatch and to cooperate in all material respects
with the first party's and its Affiliates' efforts in connection therewith.

     13.3 PUBLICITY. Except as otherwise required by law or applicable stock
exchange rules, press releases and other publicity concerning this transaction
shall be made only with the prior agreement of the Seller and Purchaser (and, in
any event, Seller and Purchaser shall use all reasonable efforts to consult and
agree with each other with respect to the content of any such required press
release or other publicity). Except as otherwise required by law or applicable
stock exchange rules, no such press releases or other publicity shall state the
amount of the Purchase Price.

     13.4 NOTICES. All notices required or permitted to be given hereunder shall
be in writing and may be delivered by hand, by facsimile, by nationally
recognized private courier, or by United States mail. Notices delivered by mail
shall be deemed given three (3) business days after being deposited in the
United States mail, postage prepaid, registered or certified mail, return
receipt requested. Notices delivered by hand, by facsimile, or by nationally
recognized private carrier shall be deemed given on the first business day
following receipt; provided, however, that a notice delivered by facsimile shall
only be effective if such notice is also delivered by hand, or deposited in the
United States mail, postage prepaid, registered or certified mail, on or before
two (2) business days after its delivery by facsimile. All notices shall be
addressed as follows:

                           If to Seller
                           Addressed to

                           OrthoLogic Corp.
                           1275 West Washington Street
                           Tempe, Arizona  85281
                           Attention:  Thomas R. Trotter
                           Telecopier:  (602) 286-5284
<PAGE>
                           with a copy to

                           Quarles & Brady Streich Lang, LLP
                           2 North Central Avenue
                           Phoenix, Arizona  85004
                           Attention:  P. Robert Moya, Esq.
                           Telecopier:  (602) 230-5598

                           If to Purchaser
                           Addressed to

                           OrthoRehab, Inc.
                           650 Suffolk Avenue, Suite 100
                           Lowell, Massachusetts  01854
                           Attention:  Frank P. Magliochetti, Jr.
                           Telecopier:  (978) 656-9668

                           with a copy to

                           Gadsby Hannah LLP
                           225 Franklin Street
                           Boston, Massachusetts 02110
                           Attention:  Lawrence H. Gennari, Esq.
                           Telecopier:  (617) 345-7050

and/or to such other respective addresses and/or addressees as may be designated
by notice given in accordance with the provisions of this Section 13.4.

     13.5 EXPENSES. Except as set forth in Article X, each party hereto shall
bear all fees and expenses incurred by such party in connection with, relating
to or arising cut of the execution, delivery and performance of this Agreement
and the consummation of the transaction contemplated hereby, including, without
limitation, financial advisors', attorneys', accountants' and other professional
fees and expenses.

     13.6 ENTIRE AGREEMENT. This Agreement and the Purchaser's Ancillary
Documents and the Seller's Ancillary Documents (the Purchaser's Ancillary
Documents and the Seller's Ancillary Documents together being referred to herein
as the "Ancillary Agreements") constitute the entire agreement between the
parties and shall be binding upon and inure to the benefit of the parties hereto
and their respective legal representatives, successors and permitted assigns.
Each exhibit, schedule and the Disclosure Schedule, shall be considered
incorporated into this Agreement and the Ancillary Agreements. The parties make
no representations or warranties to each other, except as contained in this
Agreement and the Ancillary Agreements, and any and all prior representations
and warranties made by any party or its representatives, whether verbally or in
writing, are deemed to have been merged into this Agreement and the Ancillary
Agreements, it being intended that no such prior representations or warranties
shall survive the execution and delivery of this Agreement and the Ancillary
Agreements.

     13.7 NON-WAIVER. The failure in any one or more instances of a party to
insist upon performance of any of the terms, covenants or conditions of this
Agreement, to exercise any right or privilege in this Agreement conferred, or
the waiver by said party of any breach of any of the terms, covenants or
conditions of this Agreement, shall not be construed as a subsequent waiver of
<PAGE>
any such terms, covenants, conditions, rights or privileges, but the same shall
continue and remain in full force and effect as if no such forbearance or waiver
had occurred. Except as provided in Section 11.4(a), no waiver shall be
effective unless it is in writing and signed by an authorized representative of
the waiving party.

     13.8 COUNTERPARTS. This Agreement may be executed in multiple counterparts,
each of which shall be deemed to be an original, and all such counterparts shall
constitute but one instrument.

     13.9 SEVERABILITY. The invalidity of any provision of this Agreement or
portion of a provision shall not affect the validity of any other provision of
this Agreement or the remaining portion of the applicable provision.

     13.10 APPLICABLE LAW. This Agreement shall be governed and controlled as to
validity, enforcement, interpretation, construction, effect and in all other
respects by the internal laws of the State of Delaware applicable to contracts
made in that State, without giving effect to any choice or conflict of law
provision or rules that would cause the application of the laws of any
jurisdiction other than the State of Delaware.

     13.11 BINDING EFFECT; BENEFIT. This Agreement shall inure to the benefit of
and be binding upon the parties hereto, and their successors and permitted
assigns. Nothing in this Agreement, express or implied, is intended to confer on
any person other than the parties hereto, and their respective successors and
permitted assigns any rights, remedies, obligations or liabilities under or by
reason of this Agreement, including, without limitation, third party beneficiary
rights.

     13.12 ASSIGNABILITY. Except in the event of a merger, sale, or other
combination of the Company involving the sale or exchange of either (a) a
majority of the voting power of its capital stock or (b) all or substantially
all of its assets, this Agreement and the rights, interests and obligations
hereunder shall not be assignable by Seller without the prior written consent of
the Purchaser. Purchaser may (a)assign any or all of its rights or interests
hereunder to one or more designee or to NCFE or one or more of its Affiliates
and (b)designate one or more designee to perform its obligations hereunder (in
any such case, the Purchaser nonetheless shall remain responsible for the
performance of its obligations under this Agreement).

     13.13 AMENDMENTS. This Agreement shall not be modified or amended except
pursuant to an instrument in writing executed and delivered on behalf of each of
the parties hereto.

     13.14 HEADINGS. The headings contained in this Agreement are for
convenience of reference only and shall not affect the meaning or interpretation
of this Agreement.

     13.15 GOVERNMENTAL REPORTING. Anything to the contrary in this Agreement
notwithstanding, nothing in this Agreement shall be construed to mean that a
party hereto or other person must make or file, or cooperate in the making or
filing of, any return or report to any governmental authority in any manner that
such person or such party reasonably believes or reasonably is advised is not in
accordance with law.
<PAGE>
     13.16 CONSENT TO JURISDICTION. This Agreement has been executed and
delivered in and shall be deemed to have been made in Wilmington, Delaware.
Seller and Purchaser each agrees to the exclusive jurisdiction of any state or
Federal court within the City of Wilmington, Delaware, with respect to any claim
or cause of action arising under or relating to this Agreement, and waives
personal service of any and all process upon it, and consents that all services
of process be made by registered mail, directed to it at its address as set
forth in Section 13.4, and service so made shall be deemed to be completed when
received. Seller and Purchaser each waives any objection based on forum non
conveniens and waives any objection to venue of any action instituted hereunder.
Nothing in this paragraph shall affect the right of Seller or purchaser to serve
legal process in any other manner permitted by law.

     13.17 CURRENCY. Unless otherwise indicated, each of the parties hereto
acknowledges that all references in this Agreement to "dollars" or "$" shall
mean United States dollars.

     13.18 NO THIRD PARTY BENEFICIARIES. Except as otherwise provided herein,
this Agreement shall not confer any rights or remedies upon any person or entity
other than the parties and their respective successors and permitted assigns.

     13.19 CONSTRUCTION. The parties have participated jointly in the
negotiation and drafting of this Agreement. In the event an ambiguity or
question of intent or interpretation arises, this Agreement shall be construed
as if drafted jointly by the parties and no presumption or burden of proof shall
arise favoring or disfavoring any party by virtue of the authorship of any of
the provisions of this Agreement. Any reference to any federal, state,
provincial, local, or foreign statute or law shall be deemed also to refer to
all rules and regulations promulgated thereunder, unless the context requires
otherwise. The word "including" shall mean including without limitation. Nothing
in the Disclosure Schedule shall be deemed adequate to disclose an exception to
a representation or warranty made herein unless the Disclosure Schedule
identifies the exception with particularity and describes the relevant facts in
detail. Without limiting the generality of the foregoing, the mere listing (or
inclusion of a copy) of a document or other item shall not be deemed adequate to
disclose an exception to a representation or warranty made herein (unless the
representation or warranty has to do with the existence of the document or other
item itself. The parties intend that each representation, warranty, and covenant
contained herein shall have independent significance. If any party has breached
any representation, warranty, or covenant contained herein in any respect, the
fact that there exists another representation, warranty, or covenant relating to
the same subject matter (regardless of the relative levels of specificity) which
the party has not breached shall not detract from or mitigate the fact that the
party is in breach of the first representation, warranty, or covenant.

     13.20 SPECIFIC PERFORMANCE. Each of the parties acknowledges and agrees
that the other party would be damaged irreparably in the event any of the
provisions of this Agreement are not performed in accordance with their specific
terms or otherwise are breached. Accordingly, each of the parties agrees that
the other party shall be entitled to an injunction or injunctions to prevent
breaches of the provisions of this Agreement and to enforce specifically this
Agreement and the terms and provisions hereof in any action instituted in any
court of the United States or any state thereof having jurisdiction over the
parties and the matter in addition to any other remedy to which it may be
entitled, at law or in equity.

         [REMAINDER OF PAGE INTENTIONALLY BLANK/SIGNATURE PAGE FOLLOWS]
<PAGE>
     IN WITNESS WHEREOF, the parties have executed this Agreement on the date
first above written.

SELLER:

ORTHOLOGIC CORP.                            ORTHOLOGIC CANADA LTD.

By: /s/ Thomas R. Trotter                   By: /s/ Thomas R. Trotter
    ----------------------------------          --------------------------------
    Name: Thomas R. Trotter                     Name: Thomas R. Trotter
    Title: President and CEO                    Title: President and CEO

PURCHASER:

ORTHOREHAB, INC.                            2002819 ONTARIO LIMITED

By: /s/ Frank P. Magliochetti, Jr.          By: /s/ Frank P. Magliochetti, Jr.
    ----------------------------------          --------------------------------
    Name: Frank P. Magliochetti, Jr.            Name: Frank P. Magliochetti, Jr.
    Title: Chief Executive Officer              Title: President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00042-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00042-of-00352.parquet"}]]